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Abstract 
The aim of this thesis is to suggest a Go-to-Market Strategy for the Green Extraction and Impregnation 
(GEI) technology, which uses supercritical carbon dioxide based processes. 
 
The first step of this project consisted in studying deeply all the technical features of the GEI 
technology and the second in listing several possible applications for the GEI and compare them in 
terms of innovation and market need. The analysis lead us to conclude that the application of GEI in 
dental prosthesis is very promising, from the point of view of the market. Two possible applications 
were considered: i) GEI as a way to remove contaminants after the preparation of  the  dental 
prostheses   - extraction of methyl methacrylate, which is responsible for allergies, from the acrylic, a 
material used in dental prostheses - and ii) the use of GEI for the impregnation of dental prostheses  
with therapeutic active principles. We developed a commercial device under the name GEI dental and 
submitted it to experimental tests, which allowed the validation of the above mentioned applications.   
Despite the patent expiration of the GEI technology, there is the possibility to patent a prototype of the 
GEI dental device.  
 
The business model presupposes the creation of a start-up, Sustainable Solutions (SS) constituted by 
a team of highly qualified specialists in different areas. It will be responsible for assembling the product 
and for the sale of the GEI dental to dental laboratories. The target market are the large European 
laboratories, which are interested in innovation and with a solid financial situation. Portugal is the entry 
market. About 20% of Portugal’s population is dental prostheses users and the number of Portuguese 
companies, which might be interested in buying the product, is more than 300.  
 
The product should be positioned as a high quality new device, which, at same time, meets a need of 
orthodontia specialists, adds value to dental prostheses and belongs to a new generation of 
environmentally friendly products. 
 
The necessary investment to create SS is about 200 000 €. 
  
 
 
 
 
 
 
 
 
 
Keywords: Supercritical carbon dioxide; Green Extraction and Impregnation (GEI); Methyl 
methacrylate; Dental prosthesis; Dental laboratories; Environmentally friendly products. 
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Resumo 
 
O objetivo deste trabalho é sugerir uma “Go-to-Market Strategy” para a tecnologia Green Extraction 
and Impregnation (GEI), que utiliza dióxido de carbono supercrítico.  
 
A primeira etapa deste projecto consistiu em estudar as características técnicas da tecnologia, e 
segundo passo foi listar várias possíveis aplicações para o GEI e compará-las em termos de inovação 
e necessidade de mercado. Esta análise levou-nos a concluir que a aplicação da GEI a próteses 
dentárias é muito promissora do ponto de vista do mercado. Duas possíveis aplicações foram 
consideradas: i) GEI como via de remoção de contaminantes após a preparação das próteses 
dentárias-extracção do meti metacrilato, que é responsável por alergias, do acrílico, um material 
usado em próteses dentárias- e ii) o uso do GEI para a impregnação de próteses dentárias com 
princípios activos terapêuticos. Um dispositivo comercial designado GEI dental foi desenvolvido e 
submetido a testes experimentais, que permitiram a validação das aplicações mencionadas acima. 
Apesar da patente da tecnologia GEI ter expirado, existe a possibilidade de patentear um protótipo do 
equipamento GEI dental. 
 
O modelo de negócios pressupõe a criação de uma “start-up”, Sustainable Solutions (SS), constituída 
por uma equipa de especialistas altamente qualificados em diferentes áreas, que será responsável 
pela montagem e pela venda do GEI dental aos laboratórios de prótese dentária. O mercado alvo são 
os grandes laboratórios europeus, que estão interessados em inovação e com uma situação 
financeira sólida. Portugal é o mercado de entrada. Cerca de 20% da população de Portugal usa 
prótese dentária e o número de empresas portuguesas, que podem vir a estar interessados em 
comprar o produto, é superior a 300. 
 
O produto deve ser posicionado como um novo dispositivo de alta qualidade, que, ao mesmo tempo, 
atende a uma necessidade dos especialistas em ortodontia, adiciona valor às próteses dentárias e 
pertence a uma nova geração de produtos amigos do ambiente. 
 
O investimento necessário para criar a SS é de cerca 200 000€. 
 
 
 
 
 
 
 
 
Palavras Chave: Dióxido de Carbono supercrítico; Green Extraction and Impregnation (GEI); Metil 
metacrilato; Próteses dentárias; Laboratórios dentários; Produtos amigos do ambiente. 
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1. Executive Summary 
 
The thesis project “A Go-to-Market Strategy for Green Extraction and Impregnation” was a research 
line focused on technical innovation and the challenge of taking technologies from the laboratory to 
the market. The aim of this project was to develop a strategic line to implement a new product in the 
market with success. 
 
The Green Extraction and Impregnation (GEI) technology comprises the use of the supercritical 
carbon dioxide (scCO2) as extract and impregnation solvent. The technical features of the GEI 
technology are presented in Chapter 2.  
 
After a brainstorming exercise about the possible applications of GEI technology, the choice of the 
most promising application to develop a deep study was based on two criteria: innovation and market 
need. the application of GEI in dental laboratories seemed very promising, Two possible applications 
were considered the most interesting, from the point of view of the market: i) GEI as a way to remove 
contaminants after the preparation of the dental prostheses - extraction of methyl methacrylate (MMA), 
which is responsible for allergies, from the acrylic, a material used in dental prostheses, - and ii) the 
use of GEI for the impregnation of dental prostheses with therapeutic active principles.  
 
The dental prosthesis problems, in which GEI dental may be a solution, are discussed in the Chapter 
3. 
 
The product’s concept was tested and validated through experimental tests performed in Laboratory 
Nutraceutical and Delivery, IBET. We developed a commercial device under the name GEI dental and 
submitted it to experimental tests, which allowed the validation of the above mentioned applications. In 
this thesis, GEI dental’s components are discussed, which include a preliminary design to a future 
prototype. The description of experimental tests and the preliminary design to a future prototype are 
presented in Chapter 4. 
 
In Chapter 5 an outlook on potential market was developed focusing on the European dental market. 
Portugal will be the test market for the implementation of the GEI dental in the market, so the case of 
Portugal (number of dental laboratories and dental prosthesis users) was studied in detail. Besides 
consulting surveys and articles about dental sector, interviews were conducted with dental 
professionals, such as orthodontists, hygienic oral technicians and dental prosthesis technicians. In 
addition, two online questionnaires about dental prostheses were performed, one directed to the 
Portuguese population and the other questionnaire was answered by the Portuguese orthodontists.  
These tools were essential to study and perceive the dental industry. 
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The potential market was divided into different segments - innovation, size, geographical localization 
and financial soundness. The target market are the European large dental laboratories which present 
high interest in innovation and with a solid financial situation.  
 
The product should be positioned as a high quality new device for improving the dental prostheses, 
which, at same time, meets a need of the orthodontia, adds value to dental prostheses and belongs to 
a new generation of environmentally friendly products. 
 
Due to the nonexistence of a similar device in dental industry to GEI dental, the competitor analyses 
were made comparing the features attributed to the acrylic by GEI to the materials most commonly 
used in orthodontia (acrylic, ceramics and metals).  
 
The market analysis also includes an overview about the dental supply chain and distribution channel, 
which is based on the current dental European industry. 
 
The concerns about intellectual property and the certifications required by the regulatory authorities 
are important points to take into account when an idea is turned into a salable product. Chapter 6 is 
dedicated to discussing these points. Despite the patent expiration of the GEI technology, there is the 
possibility to patent a prototype of the GEI dental device. Concerning regulation issues, the approval 
of entities will be necessary, such as the Infarmed, as well as obtaining CE marking. 
 
The business model is discussed in Chapter 7.The business model adopted presupposes the creation 
of a new start-up, Sustainable Solution (SS) constituted by a team of highly qualified specialists in 
different areas. The company will be responsible for assembling the device and commercializing it 
(directly to the costumer or through distribution companies).  
 
In Chapter 8 the Marketing Plan to SS is presented which includes the company’s vision, mission, 
objectives, SWOT analyses and the Marketing Mix. The Marketing Mix comprises the Product 
(principal attributes of GEI dental, SS Logotype and Slogan), Promotion (direct contact and the use of 
new online platforms), Place (direct distribution in Portugal and distribution through distribution 
companies to the international market) and Price (mainly based on the costs related to materials that 
constitute the GEI dental). 
 
Chapter 9 is dedicated to discussing the product’s development (the main steps to convert the initial 
idea into a final product) and the operations plan (equipment and geographical localization). 
 
The SS team, constituted by a team of highly qualified specialists in different areas, is discussed in 
Chapter 10.  
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The Chapter 11 is dedicated to the implementation, which comprises the financial plan and the critical 
risks. The financial plan was supported, whenever it is possible, in real values. The sales were based 
on estimated values, the most similar as possible to reality, in order to present a financial analysis the 
most reliable as possible. The critical risks appointed are the high price of components of the product 
which is reflected on the product’s price, idea being recent and there are still several points to be 
developed and improved, and the possibility of the sales projections fail. 
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2. Technology 
 
2.1. Description of the technology 
 
A patented technology entitled “Impregnation method of biocompatible polymeric matrices with 
application in food, cosmetic and/or pharmaceutical industry using a clean technology” is the chosen 
technology to develop a Technology-Market Transfer Plan. The technology has emerged in the frame 
of a previous project about contact lenses impregnation, which patent ended up to expire. This project 
was initiated by PhD. Catarina Duarte and by a Master student, as a result of a Master project about 
active principles impregnation. 
 
Nowadays, one of the most important global concerns is the waste produced and accumulated from 
chemical process. There is a growing   interest   about   environmentally   friendly technologies, mainly 
in sensitive issues such as health care and food [1]. Therefore, natural biodegradable materials and 
cleaner technologies, namely Supercritical Fluid (SCF) based processes, are of growing interest 
worldwide [2].  
 
The present invention consists of an impregnation method of polymeric matrices using a cleaner 
technology. In particular, this invention reports to an impregnation method of one or a group of 
antioxidants or bio active additives in biocompatible polymers that can be either biodegradable or not, 
by using a Green Extraction and Impregnation (GEI) technology, specifically through the use of 
compressed fluids. Then technical concepts about SCF based processes applied to polymeric 
matrices will be exposed in this section. 
2.1.1. Supercritical fluids  
 
 A pure substance can exist in a solid, liquid or gas phase, which are evidently defined by phase 
boundaries. The pressure-temperature phase diagram of a pure substance presents a triple point, in 
which three different phases can be distinguished, solid, liquid, and gas (Figure 2.1). The point on the 
boundary curve is called the critical point and when the temperature and pressure increase above the 
critical point, liquid and gas phases coexist [3]. Compressed fluid is a fluid, at high pressures and that 
can still exist in a liquid state. [2]. A supercritical fluid is a fluid at a pressure and temperature above its 
thermodynamic critical point.  
 
 
6 
 
 
Figure 2.1. Pressure-temperature phase diagram of a pure substance [3]. 
 
The supercritical fluids have some similar properties to those of liquids, like their density, and other 
properties similar to gases, such as low viscosities and large diffusivities [4]. Therefore, this may mean 
that a supercritical fluid can easily penetrate inside a solid matrix (including polymeric matrices) and 
extract or precipitate substances from/into them. This can be done through a simple manipulation of 
pressure or temperature near the critical point, which offers the equivalent of using different solvents, 
consequently providing selective extraction properties or impregnation capacity.  Supercritical fluids 
usually have excellent plasticizers properties and are able to swell polymeric matrices, thus promoting 
the diffusion of substances into them and, consequently, allowing the processes of extraction and 
impregnation to be carried out [2]. The fluids under supercritical media are gases at room temperature 
and atmospheric pressure. As a result, it is quickly dissipated and can be easily recovered after the 
process, upon release of pressure leaving no toxic solvent residue behind [5-6].  
2.1.2. Carbon dioxide 
 
Supercritical carbon dioxide (scCO2) ‘‘generally recognized as safe” (GRAS) solvent is the most 
commonly used SCF, because it is abundant and cheap, non-flammable and relatively inert. Besides, 
it is soluble in aqueous media and it can plasticize and decrease the glass transition temperature of 
most polymeric materials. Furthermore, it presents low operation temperatures involved in supercritical 
processes (Tc =31◦C and Pc = 73 bar). This allows working at relatively low temperatures, suitable for 
thermally labile substances [7-10]. Due to the fact that scCO2 processes operate at mild conditions, 
active principals (biologically active or medical ingredients) can be incorporated into polymer 
substrates without interfering with the performance of the substance [10-11]. The carbon dioxide (CO2) 
is used to both dissolve the drug and swell the polymer, thus enabling rapid impregnation. Since it 
replaces organic solvents, supercritical fluid impregnation is presented as a green process [12]. 
Compared to the common liquid plasticizers, scCO2 penetrates deeper into dense polymeric networks 
and can be easily removed after processing with a simple depressurization [12-18]. The advantages 
shown by Supercritical Solvent Impregnation (SSI) and Supercritical Fluid Extraction (SFE) using 
scCO2 for the development of drug impregnated polymeric materials can be used as Drug Delivery 
Systems (DDSs) for many biomedical applications [19-20]. In addition, the SSI allows the 
homogeneous impregnation of polymeric matrices with drugs in a relatively short time. When properly 
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employed, it does not alter nor damages polymeric matrices physical, chemical, and mechanical 
properties. Depth of penetration and drug load can be easily controlled by the regulation of several 
operational conditions [21-24]. The scCO2 can be also used with the purpose of extracting undesired 
residual solvents, oligomers or monomers, or any other additives present in polymeric materials [12, 9-
10, 14-16, 22, 25].  
 
2.1.3. Polymers 
 
In the last years the behavior of different classes of polymers in supercritical media has been 
extensively studied. An area that has become a source of interest in polymer science, mainly polymer 
synthesis and processing, is the manipulation of the physical properties and their selective control [18, 
26-27]. Some examples of areas where polymers are usually used are the pharmaceutical and 
medicinal industries, or even in food packaging [13]. There are many polymeric matrices that might be 
impregnated by this method and several have already been tested. The polymeric matrices can be 
polymers, copolymers or mixtures of both. The polymeric matrices can be impregnated with an 
additive or a group of them, according to the purpose it was intended. The additives should be soluble, 
in certain degree, in a fluid or in a mixture of fluids and co-solvents, to be used as a plasticizing agent 
for the polymeric matrix [2]. The CO2  is susceptible of being dissolved by majority of polymers at high 
pressure, reaching a concentration up to 10–30 wt% (causing a significant swelling of the polymer). 
The diffusion rate and penetration of solute molecules into the polymeric matrix is improved by an 
increase in the free volume of CO2-swollen polymers [12]. The impregnation results from a balance of 
interactions between supercritical fluids, drugs and polymers. There is absorption or a 
physicochemical attachment of drug molecules to the polymeric matrix. So, the CO2 acts as a 
temporary plasticizer to assist the adsorption of additives into polymers, as it promotes an increase in 
the linear dimension of the polymer, thus improving the kinetics of absorption of the diffusing 
substances [28-30]. The solvent power of the scCO2 can be abruptly decreased by decompression. As 
a consequence, the active compound previously dissolved in the supercritical fluid precipitates, as well 
as it occurs the contraction of the carrier matrix [31]. 
 
2.1.4 Conventional impregnation processes 
 
The conventional impregnation processes consists of the immersion of a polymeric matrix into a 
solution, which can be aqueous or organic, where an additive was previously dissolved.  However, this 
method presents disadvantages, such as the use of toxic organic solvents, the majority of polymers 
cannot be impregnated by this method due to the additives’ low diffusivity which results in low rates of 
impregnation. In addition, the increase of temperature to enhance the process can degrade the 
polymer. Also on a posterior stage the system should be submitted to high temperatures to remove the 
organic solvents, which can also degrade the active principle [1,32-33]. Other common impregnation 
method is performed during the polymerization reaction. The additives are mixed initially with the 
monomers and solvents. During polymerization the polymers are formed and the additive is physically 
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retained inside of the solid polymeric matrix [2]. Due to the specific properties of supercritical fluids 
described above, they are usually good solvents. Properties as superficial tension being barely zero, 
low viscosity and high difusivity, allows that the supercritical impregnation process may be faster and 
more efficient than the conventional processes [32-34]. Therefore, the present green technology has 
characteristics that can replace traditional methods of impregnation, such as the immersion of a 
polymeric matrix into a solution or reactions of polymerization, thereby avoiding typical disadvantages 
associated with each one of the traditional methods [2].  
2.1.5. Summary of the main advantages of GEI 
 Below it is summarized the main advantages of GEI: 
 This method allows an easy control of the amount to be impregnated and the depth of additive 
impregnation, and in the end the additive is homogeneously dispersed in the polymeric matrix.  
 
 Another very important issue is that the impregnation is made without leaving any residues of 
dangerous solvent in the polymeric matrix. The recovery of the final product is a simple and 
easy process, only made by expansion of the system. In the end, the products are recovered 
dry and free of solvent, without the need of any additional steps of drying/evaporation (and 
without the energetic costs and the time consuming of an operation associated with this 
process).  
 
 Generally the polymeric matrix mechanic and physic properties are not changed or damaged, 
and their constituents, such as additives, polymers and copolymer are also protected from 
degradation. 
 
The advantages mentioned above are very important in products to human consumption or contact, 
because the residual presence of organic, dangerous and/or toxic solvents is rigorously established 
and controlled by international organizations and safety rules. Thus, it is necessary to ensure the 
complete removal and absence of such substances without exposing the substances to high 
temperatures, which may eventually lead to thermal degradation [2]. 
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2.2. Possible applications 
 
Below it is discussed several possible applications for the GEI technology.  
 
Food industry 
 
a) The antioxidants are emerging as prophylactic and therapeutic agents. An impregnated 
gum with an antioxidant could be an option for this technology. The gum would have edible 
nanoparticles, such as xanthan gum impregnated with antioxidant, so that when it is chewed up the 
nanoparticles are released. The principles of the new drug delivery systems are a useful tool to 
significantly improve the performance of the antioxidants. Consequently, this method is a useful 
alternative to allow a good performance of the antioxidants. 
 
b) An important issue is the conditions of storage of the food in order to avoid the food 
deterioration. This technology, applied to packages, will enable the increasing of the lifetime, or the 
quality of products, that are stored. The inside of the package would be coated by a polymeric film of 
polyethylene and it is impregnated with an antimicrobial agent or an antioxidant which is freed along 
time. The storage of fresh fish, in order to prevent a quick degradation and the transport of fruit for 
long distances, are examples of possible situations where this package would be useful. 
 
Pharmaceutical industry 
 
c) Bad breath is a problem which gives social constrains. A buccoadhesive for a good breath 
can be a solution to the presented problem. In order to prolong the drug residence time in the oral 
cavity, buccoadhesive drug delivery systems have been created. The referred system is made of 
mucoadhesive materials which swell upon contact with aqueous media and outer viscous layers [35]. 
An example of a natural polymer which can be used as a bioadhesive material is chitosan [36].  This 
technology can allow the impregnation of the mentioned polymer with an antimicrobial solution with a 
fresh fragrance. The buccoadhesive would be put in the customer’s mouth and the solution would be 
freed throughout the day. So, this technology would allow a healthy mouth and a good breath during 
the day. 
 
d) The present technology can be very useful in systems of drug delivery that have been 
developed recently. There is an increasing study and development of drug delivery systems that only 
releases its payload in specific conditions such as pH or temperature, a feature that could be 
particularly useful for targeted delivery of cancer treatments. Most of these systems use nanoparticles 
as drug carriers, so this technology is an option to impregnate the nanoparticles without unnecessary 
losses and without leaving any dangerous residue of solvent. 
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e) The mite is the main agent of allergies in a house. Another possible application of this 
technology is the fabrication of mattress covers anti - dust mites. The mattress cover would have a 
polymeric matrix impregnated with a solution to kill dust mites. The use of this technology would allow 
the impregnation of a large amount of the solution in the mattress cover, in order to the effect against 
the dust mites to last a long period of time. At the same time, the polymeric matrix would be 
decomposed and the solution would be freed. There are some examples of substances that have 
been used to kill the dust mites, such as benzyl benzoate, natamycin and others.  
 
f) The infestation by insects, such as ticks and fleas is a major problem for most animals. 
Besides giving a great discomfort to the animal due to the itching, they are also responsible for the 
transmission of infectious diseases. An insecticidal collar is a possible device to protect animals from 
fleas and ticks. The technology would allow the impregnation of the referred collars with enough 
pesticide to continually kill fleas for a long period of time. The pesticide must be safe and non-toxic 
because, on the one hand, it has a prolonged skin contact, and on the other hand, the animal may 
chew the collar.  There are various examples of the polymers, which can be form the casing of the 
collar, such as cellulose plastics, and natural elastomers, such as the rubber. The present green 
technology allows the collar to have a considerable amount of insecticidal without using high 
temperatures, unpleasant odors free, and waste of insecticidal. 
 
g) Insect bites are a common problem in many parts of the world and are responsible for the 
spread of diseases like typhoid or malaria. While in Portugal the diseases transmission by insect bites 
is very rare, it is uncomfortable and many people are very sensitive to insect bites. Accordingly, an 
insecticidal bracelet, or a belt similar to the application described above, is another possible 
application, but for humans. This bracelet would be very useful for people which go to places where 
the mosquitos are a problem because it is a practical way to keep the mosquitos away. Comparing to 
traditional methods, such as repellent spray or a head net, the bracelet is more practical and resistant 
method. 
 
h) A polymer impregnated with an additive can be used in adhesives that will help embed the 
drug into the skin and provide a controlled drug delivery. The adhesives can be used, for example, by 
injured athletes during an important competition, in the treatment of burns or back pain. The system 
consists of two polymer layers: an external, which prevents the loss of the drug and controls the 
release and the other layer is an adhesive layer responsible for establishing the system into the skin. 
The polymer matrix impregnated with the drug is sandwiched between the two polymer layers. An 
example of a polymer most commonly used, in preparing the matrix systems, is cross-linked 
poly(ethylene glycol) [37].  
 
i) One of the most common complaints of new parents is the difficulty to give medication to 
their babies. This technology would allow parents to give the medication as their babies suck the 
pacifier in a simple and practical way. The pacifier would be composed of two parts, a disposable part 
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containing the drug to be administered and another which would serve as support to the disposable 
part. The disposable part would be a silicone nipple or a biodegradable polymer so, when the baby 
sucked, the drug would be freed through the pores of the polymer. The medicine pacifier would be a 
solution when the parents do not know how to give the medicine to their baby or when the baby is very 
agitated. 
 
j) Another feature related to the application mentioned above is the difficulty to give medication 
to pets. Associating the technology to the pet’s toy, the toy may be an option for the taking of the 
medicine. The object would have the flavor or smell of food, so when the pet bit the object the drug 
would be freed and enter in the organism of the pet. The pet’s toy would be composed of successive 
layers impregnated with medication and coated with a polymeric matrix, such as 
hydroxypropylcellulose, in order to the medication to be released.  
 
k) The impregnation method can be used in medical devices, such as catheters, the material 
of which is impregnated with one or more antimicrobial agents to inhibit the growth of bacterial and 
fungal organisms. There are already various methods that have previously been employed to coat the 
surface of medical devices with an antibiotic. The medical device may have a polymeric surface such 
as polyethylene, impregnated with antimicrobial agent, such as rifampin without traces of solvent and 
with sufficient antimicrobial agent in order to last longer [38]. 
 
l) MMA has the potential to provoke inflammation, irritation, and allergic response of the oral 
mucosa. Acrylic resins used in dental prostheses contain MMA as residual monomer which is released 
when the patient uses the prostheses. Therefore, residual monomer is undesired as it is capable of 
producing both stomatitis and an angular cheilitis [39].  
 The technology can be applied to the dental prostheses, specifically to the acrylic.  The application 
comprises the utilization of supercritical fluids, specifically ScCO2, to extract undesired residual 
monomer, the MMA and to impregnate a polymeric matrix of poly (methyl methacrylate) (PMMA) with 
an active substance. The referred polymer is used in dental prostheses either removable or fixed. A 
dental prosthesis that dispenses a useful substance, such as an anti-inflammatory or a solution for a 
good breath, is going to be released in the oral cavity during the time the patient is using the dental 
prosthesis.  
 
Agriculture industry 
 
m) One area where this technology may also be useful is agriculture. Nowadays there are 
already procedures to decrease organic contaminants in groundwater, soils and sediments by using 
biodegradable polymer-coated nanoparticles into the contaminated area. The method is about 
introducing polymer coated nanoparticles which would show an enhanced ability to migrate through 
the soil and would provide a proper treatment in the contaminated area [40]. A biodegradable polymer, 
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such as alginate biopolymer or ethyl cellulose, could be impregnated by this green technology with 
substances which react with the contaminants in situ to eliminate them, breaking them down into less 
harmful substances. 
 
Cosmetic industry 
 
n) A growing concern of hygiene products is the smell. A diaper with a good smell could be 
made using this green technology by the coating of a polymeric layer, such as a natural rubber, 
impregnated with a fragrance. When the customer use the diaper, the polymer would be destroyed 
and the fragrance would be released. Despite being an option for both baby and adult diapers, 
probably the second option would have greater acceptance. 
 
o) A cleaning cloth embedded with a detergent or disinfectant can be another option for 
applicating this technology. The cleaning cloth would have a system where nanoparticles carry the 
detergent or disinfectant. When the customer presses the cleaning cloth, the nanoparticles would be 
released and broken up, and finally the detergent or disinfectant would be freed.  Therefore, two 
products would be joining into one and in addition the proposed cleaning cloth would be more hygienic 
compared to the commonly cleaning cloths. This product might have a particularly acceptance in 
restoration, in which the hygiene rules are increasingly restricted. 
 
p) Sponge impregnated with bath gel is a practical and simple option. Usually, the user 
purchases separately the sponge and the bath gel. The proposed product would allow the customer to 
get both products buying a single one. The environmental concern will already be present not only on 
the technology used but also on the product if all the material used would be biodegradable. The 
sponge would have a polymeric matrix, such as the alginate impregnated with bath gel. 
 
q) A similar idea is a sponge impregnated with self-tanning. The product would be very useful 
since not only would allow customers to buy two products into one, but also cleaner and more 
practical one. The product would answer a customer’s need because it would allow a more 
homogeneous application of the self-tanning. The sponge would have a system where mesoporous 
poly (acrylic acid) nanoparticles carries self-tanning and, when the customer used the sponge, the 
nanoparticles would be released and broken, and finally the self-tanning would be freed. 
 
r) An insole that frees a pleasant smell would be another possible application for this 
technology. The insole would be composed by multiple layers to provide proper support and 
cushioning to the foot. The superior layer would be a polymer of cellulose impregnated with a perfume 
or a deodorant. The present technology would allow the impregnation of a considerable amount of 
perfume, so the fragrance of the insole would be kept over a long period of time. The insole could be 
used in tennis, shoes or in skates.  
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The advantages and disadvantages of the different applications of the technology are summarized in 
Table 2.1.  
 
 
  Table 2.1. A summary of the advantages and disadvantages of technology applications. 
 
 
Applications 
 
Advantages 
 
Disadvantages 
 
 
 
 
Food Industry 
 
Antioxidant 
gum 
 The product is new 
 Environmentally friendly 
 It is a healthier product 
 Antioxidants are in great 
demand 
 Environmentally friendly 
 It is expensive 
 Possibly there are other 
simpler and cheaper ways to 
impregnate a gum with 
antioxidant 
 
 
 
Package 
 It keeps the properties of the 
food inside the package for a 
longer time, which is very 
interesting in the case of fresh 
food (fish, fruits, etc.).  
 Environmentally friendly 
 It is expensive  
 The use of a drug in food 
may not be well accepted by 
the  general public 
 
 
  
Pharmaceutical Industry 
 
 
 
Buccoadhesive 
to good breath 
 The product is new 
 It allows to maintain the 
mouth healthy and fresh all 
day 
 Environmentally friendly  
 It is expensive 
 There are other products 
with the same purposes and 
probably cheaper 
 
Drug delivery 
systems 
 It avoids unnecessary losses  
 It does not  leave any 
dangerous residue of solvent 
 Environmentally friendly 
 It is expensive 
 There are already other 
methods of impregnation  
Anti-dust mites 
mattress cover 
 Long term 
 More efficient 
 Environmentally friendly 
 
 It is expensive 
 There are another products 
with same purpose 
 
Insecticidal 
collar 
 Long term 
 Resistant  
 Environmentally friendly 
 It is expensive 
 Product already widely 
marketed 
 
Insecticidal 
bracelet 
 Practical 
 Simple 
 Long term 
 Resistant  
 Environmentally friendly 
 
 
 It is expensive  
 
 
Adhesives 
 Long term 
 Resistant  
 Practical 
 Environmentally friendly 
 It is expensive 
 Adhesive may not adhere 
well to all types of skin 
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Applications 
 
Advantages 
 
Disadvantages 
 
 
Medical pacifier 
 The product is new 
 Easy way to administer 
medication to babies 
 Environmentally friendly 
 It is expensive 
 Disposable 
 
 
Pet toy 
 The product is new 
 Easy way to administer 
medication to pets 
 Environmentally friendly 
 
 It is expensive  
 Difficulty controlling the 
amount of drug that the 
animal takes  
 
 
Medical advices 
 Avoid the contamination of 
medical advices  
 Avoid the need to remove and 
replace of medical advices 
 The effectiveness of the 
coating lasts longer 
 Environmentally friendly 
 It is expensive  
 There are others method of 
impregnation which are 
already used 
 
Dental 
prosthesis that 
dispense 
medicine 
 The product is new 
 Solution for many people who 
have a problem with dentures 
 Environmentally friendly 
 It is expensive 
 
 
 
  
Agriculture Industry 
 
 
Agriculture 
 Environmentally friendly 
 It is expensive  
 There already are other 
methods of impregnation  
  
Cosmetic Industry 
 
 
 
Smelly diaper 
 Allows comfort and relaxation 
for diapers’ users 
 It is expensive  
 Disposable 
 
Cleaning cloth 
with detergent 
 Two products into one 
 Cleaner than a simple cloth 
 Environmentally friendly 
 It is expensive  
 A simple cloth is already 
used a long time 
 
Sponge bath 
shower 
 Two products into one 
 Practical to use and carry 
 Environmentally friendly 
 It is expensive  
 
Sponge self-
tanning 
 Two products into one 
 Practical to use and carry 
 Allows a uniform and clean 
application (without stains) 
 Environmentally friendly 
 It is expensive  
 
 
 
Insoles 
 The product is new 
 Solution for the bad smell of 
the feet 
 Environmentally friendly 
 It is expensive  
 Disposable 
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Each application for the GEI technology was analyzed in terms of innovation and market need (Table 
2.2).The innovation refers to the use of a new idea or method that was not thought of yet, but it does 
not imply that it is useful.  The market need refers to the need and utility about a specific service or 
product to the customer. 
 
Table 2.2. Analysis of market need and Innovation of technology applications. 
 
  
Innovation 
 
No Innovation 
 
Market need 
 
 
 
c); i); l); r); s) 
 
d) 
 
No Market need 
 
j)  
 
a); b); e); f); g); h); k); m):n); 
o); p); q) 
 
Note:  a) Antioxidant gum; b)Package; c) Buccoadhesive to good breath; d) Drug delivery systems; e)  
Anti-dust mites mattress cover; f) Insecticidal collar; g) Insecticidal bracelet; h) Adhesives; i) Medical 
pacifier; j) Pet toy; k) Medical advices; l) Dental prosthesis that dispense medicine; m) Agriculture; n) 
Smelly diaper; o) Cleaning cloth with detergent; p) Sponge bath shower; q) Sponge bath shower; 
r)Sponge self-tanning; s) Insoles 
 
As it is possible to observe in Table 2.2, most applications were classified as having no innovations 
and no market need. These products are the less interesting to develop a more earnest study. The 
quadrant related to the axes market need and no innovation has only one application- drug delivery 
systems.  There is an increasing study and development of drug delivery systems and this technology 
can be a good choice to be applied in these systems but there are already many other viable choices. 
Such as the previous quadrant, the quadrant referred to the axes no market need and innovation has 
only one application- the pet toy.  Despite this applications being innovative, apparently they do not 
have a market. The applications in quadrant related to the axes market need and innovation are the 
most interesting to be developed. The Buccoadhesive to good breath is an interesting product but the 
present technology is expensive, so probably it will not be the best product for the development of a 
study. Even though the insoles and the self-tanning sponge are interesting products, they can be 
impregnated with simple and cheap methods because they do not need to be impregnated with a 
clean technology. The most interesting applications that deserve a more detailed and earnest study 
are the medical pacifier and the dental prosthesis that dispenses medicine. The medical pacifier and 
the dental prosthesis that dispenses medicine are innovative products and probably have market 
need. They both belong to the health sector, which usually has high safety levels associated. In other 
words, since healthcare deals with people’s health, they must be assured not to be exposed to any 
risk. The high levels of safety are assured by this new technology because it belongs to a new 
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generation of green technologies. The characteristics that make this technology safe are previously 
described above. 
  
2.2.1.  Market analysis of medical pacifier and dental prostheses that dispense 
medicine 
In this next section the most promising application of the technology is chosen through the comparison 
of attributes of each application with its competitors. 
2.2.1.1.  Medical pacifier 
There already exists in the market potential competitors of the medical pacifier that have 
advantageous characteristics (see Performance Map in Appendix 1). Although there is a pacifier that 
dispenses medicine in European market, in Portugal there is not a pacifier that dispenses medicine. 
Probably Portugal may be a good option to patent and market this new product. However, by 
evaluating the pacifiers available in the market (Appendix 1), it is possible to observe that they have 
more advantageous characteristics than the impregnated pacifier by GEI. The reasons that support 
the decision not to go any further with the study of this product are listed below: 
a) Since similar products are being commercialized in other European countries, Portugal is a 
much too small a country to make the product worth the commercialization; 
b) There are pacifiers with the same characteristics available  with good prices;  
c)  The available pacifiers present a better dosage control of the medicine. 
  
Therefore, due to the given reasons, the study of the medical pacifier will not be explored any further. 
 
2.2.1.2. Dental prosthesis that dispense medicine 
The application of the GEI technology to the dental prostheses was called GEI dental. After a research 
about whether there are similar devices with the identical features of the GEI dental, no device was 
found in the dental market. The interviews to the dental professionals (Appendix 2) confirmed the 
previous assumption. Therefore, it was considered that the application of this GEI technology to dental 
prostheses is a new idea. The dental industry is a rising sector both on technological development and 
on the profits it involves. Due to the aspects referred above, it is concluded that applying this 
technology to dental prostheses may be very promising.  So, the development of a study about this 
new product will be followed with great expectation. 
 
 
 
 
 
 
17 
 
3. Market pain: The value preposition of GEI dental  
 
The following Chapter is dedicated to exposing certain problems of dental prostheses, which may be 
solved by the application of GEI dental to dental prostheses. 
The wearing of removable prostheses can be associated to oral diseases, which can be due to 
microbial colonization of dental plaque, traumatic irritation by the denture or an allergic response to 
denture materials. Several studies have been reported that about 25% to 30% of complete denture 
wearers have problems with their dentures [41]. 
In odontology, biocompatibility is an essential issue. Biocompatibility refers to the context when tissues 
are in contact with a determined material and it does not manifest any type of toxic, irritant, 
inflammatory, allergic response, and severe mutagenic or carcinogenic effects [42]. Concluding, it is 
the ability to remain biologically inert during its functional period [43].  
Allergy 
The PMMA is the acrylic resin mostly used in dentistry. The material presents several applications, 
since removal devices, auxiliaries fixed devices, individual impression trays, orthodontic devices, to 
artificial crowns [44]. Since the 1960’s, there have been reports of hipper-sensibility to acrylic resins. In 
the majority of the cases, it has been associated to the presence of high content of residual monomer, 
MMA due to incomplete polymerization. The acrylic resins may cause allergic reactions with local 
manifestations, such as pain, edema, and erythema.  Reactions of systemic order may occur, with a 
higher or lower intensity, including burn feeling, deglutition difficulty, mouth edema and urticarial [45-
47]. Furthermore, according to the dental professionals addressed this problem differs from each 
patient. There are cases in which patients present a high sensibility to the use of acrylic prostheses 
and so the patient cannot use the dental prosthesis. In addition, an online questionnaire about dental 
prostheses was made available to the dentists and the sample comprises 20 dentists (see appendix 
3). One of the questions was about whether they considered important the extraction of MMA from 
dental prostheses, and the answers were unanimous, having all the dentists responded “yes”. 
According to professional addressed the demand of the extraction of MMA from dental prosthesis, in 
order to reduce the cytotoxicity of the acrylic resins, has been increasing. 
The undesired residual monomer, the MMA, can be extracted through the GEI dental. 
Malodor 
Oral malodor, also known as bad breath, is a common complaint among the population. The bad 
breath is a severe chronic problem that affects personal relationships and quality of life. According to 
Tonzetich and Ng, bad breath is a common condition found in approximately 50 % of the adult 
population [48]. 
The malodor issue also may be fought through the application of GEI dental to dental prostheses. 
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Infections 
Dental prostheses have been associated to candidiasis, which is a fungi infection. According to 
Arendorf & Walker, the use of dental prosthesis is a factor that favors the presence and development 
of various Candida specimens [49].  
Oral and prostheses hygiene are appointed in many cases, as the main responsible for infections, and 
dentists should be concerned about these factors [50]. However, the dentist cannot control the 
hygiene habits of their patients. The application of this technology to dental prostheses may allow 
dentists to improve the control of oral disorders of their patients. The impregnation of dental 
prostheses with an anti-inflammatory may allow the dentist to be certain that the patients do the proper 
treatment. 
Portugal’s case 
A questionnaire (see Appendix 4) has been applied to the Portuguese dental prosthesis users, using 
an online tool, about the problems they have had with their prosthesis and the kind of benefits they 
would like their prosthesis to allow. The sample comprises 30 individuals that use dental prosthesis. 
Among the 30 individuals inquired, about 47% refer having problems with their dental prostheses 
(Figure 3.1).  In Figure 3.2, the most reported problems by the prostheses users are presented. The 
bad adaptation of dental prostheses and inflammations are the highest percentage problems with 
about 36% of dental wearers affirming they suffer from the aforementioned problems. The GEI dental 
may be a solution to the bad adaptation and inflammation problems. 
 
Figure 3.1. Portuguese population with dental prostheses problems (data collected from online 
questionnaire). 
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Figure 3.2. Types of problems, which the dental prosthesis users usually have (data collected from 
online questionnaire). 
The GEI dental will appear in the market as a preventive technology, allowing prevention of diseases 
and infections. If the dentist observed his patient and concluded that he did not have a good oral 
hygiene, with the purpose of improving it and preventing the development of bacterial or fungi 
infection, the dentist could order a denture which gradually will release an antimicrobial or other active 
principle.  
In other cases, when the patient was already presenting an infection, the dentist could order the dental 
prosthesis with the most adequate medicine to the referred case and so the medicine will act locally. 
As an example, the GEI dental could be useful in the cases mentioned above, such as candidiasis, 
which will possibility a gradual and local administration of anti-fungi. In this case the technology will act 
as a treatment technology. 
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4. Proof GEI dental concept 
The application of the technology to dental prostheses is a new and innovative idea, so there is not 
any experimental test that validates or proves that the technology allows, at sufficient extent, the 
extraction of MMA from dental prostheses and its impregnation with therapeutic active principles.  
In order to verify the effectiveness of using GEI technology, on the one hand, for the extraction of the 
MMA from the PMMA used in dental prostheses, and, on the other hand, in the impregnation of active 
principals in PMMA, experimental tests were performed. The experimental tests were divided in two 
parts. In a first stage, the possibility to extract the residual monomer from the polymer used in dental 
prostheses was tested. In a second stage, the possibility of impregnating an anti-inflammatory drug 
was evaluated. The experimental tests were performed in Laboratory of Nutraceuticals and Delivery, 
IBET. In this Chapter only a summary of the content of the experimental tests is presented, in 
Appendix 5 the description of the experimental tests is detailed. 
 The experimental setup and the respective schematic diagram used during the experimental tests is 
depicted in Figure 4.1 and Figure 4.2 respectively.  
  
Figure 4.1. Image of installation where the tests were performed (1- High-pressure cell; 2- CO2 pump 
high pressure liquid; 3-Thermostatized water bath, 4- Pressure manometer). 
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Figure 4.2. Schematic diagram of the installation where the tests were performed (1- CO2 cylinder; 2-
Cooling coil; 3- High pressure liquid CO2 pump; 4- Valve; 5- Pressure manometer; 6-Micrometer valve; 
7-High-pressure cell; 8- Stir plate; 9-Thermostatized water bath; 10- Flow meter).  
 
This apparatus consists in a high-pressure cell (made of stainless steel) with an internal volume of 25 
cm
3
, a high pressure liquid CO2 pump (Haskel Model 29723-71), a water bath and a pressure 
manometer (Digibar II). During the experiments the cell was placed in a constant-temperature water 
bath and CO2 was pressurized with a liquid pump. A system of valves allows the CO2 to enter the cell. 
The pressure generator and the cell are provided with an electronic manometer to allow control of the 
pressure and the inlet and outlet of gas. 
The material tested were acrylic samples of the finished material used in dental prostheses, to be 
used already by patients. 
4.1. Extraction Tests 
The extraction experiments comprise the study of the effect the several operational conditions in the 
removal of MMA from PMMA, namely at different pressures, temperatures and contact times with CO2. 
The extraction tests were performed in the installation showed in Figure 4.1. The test consists in 
immersing the cell with the acrylic samples in the thermostatically bath of water after the desired 
temperature is reached and consequently pressurizing it with CO2 until the desired pressure (Appendix 
5) and stay in contact with CO2 for 20 minutes (static period). After the static period, the valves are 
opened to allow CO2 pass through the sample continuously for a defined period, named Continuous 
Period (Appendix 5). Finally, after that period, the depressurization was performed, by slow release of 
the supercritical fluid. 
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Table 4.1 Operational conditions and result of the most efficient extraction test. 
*Efficiency = Amount of MMA extracted by scCO2 / Amount of MMA initially 
The most satisfactory result was obtained at 25ºC and 70 bar in a process which during about 50 
minutes (Table 4.1), these conditions allows a reduction of 68.7% of MMA present in the samples of 
PMMA. This is a significant reduction of MMA with mild operations conditions in a relatively short time.  
In addition the samples maintained its circular shape, volume, appearance and weight. However, a 
slight whitening of the sample on the surface is verified, but it is almost imperceptible. This could be 
explained by a possible interaction of the CO2 with the dye. Therefore, the hypothesis that GEI could 
decrease the amount of MMA of acrylic resins used in dental prostheses was validated. The results 
obtained are a good starting point to future tests in order to develop and improve the GEI dental 
features allowing obtain the best efficiency that the technology could. 
4.2. Impregnation Tests 
In a second stage was tested the impregnation of ibuprofen in the acrylic resin of the dental 
prostheses. The objective is verified whether the active principle is impregnated in PMMA by the GEI 
dental. With the purpose to observe if it is possible to fulfill the objective the samples were tested in 
different conditions of pressure, temperature, CO2 contact and depressurization period.  
The impregnation tests were performed in the equipment presented in Figure 4.1 The tests consist in 
immersing the cell with the acrylic sample and the ibuprofen in the thermostatically bath of water until 
the desired temperature is reached and subsequently pressurizing with CO2 until the desired pressure 
(Appendix 5). During all tests the samples in the cell were stirred. Inside the cell, the samples were put 
on a wire support and the ibuprofen inside a metallic network, above it. 
 The tests were performed in batch during contact period (tCO2). After the tCO2, the system was 
depressurized slowly or fastly, according to the test performed (Appendix 5). 
In all test is possible observe that the samples are impregnated with ibuprofen. Different loads were 
obtained to different temperature and pressure conditions. The tests 11 and 12 present the best loads 
without changing the samples, operation condition 110 bar and 40ºC seems the better condition to 
impregnate the PMMA with ibuprofen comparing with the operation conditions tested (Appendix 5). 
However, as mentioned above, in extraction experiments, a slight whitening of the sample on the 
surface is verified, but it is almost imperceptible. For 30 minutes of tCO2 the % impregnation is about 
7% and to 60 minutes is about 8% (Table 4.2).   
 
Test 
T 
(ºC) 
P 
(bar) 
Static 
Period 
(min) 
Continuous 
Period 
(min) 
Continuous 
Period flow 
rate  
(L/min) 
𝝆CO2 
(Kg/m
3
) 
 
Efficiency* 
(%) 
Duration 
of the 
process 
(min) 
 2                                                                                                                                                                                                                                                                                                                                                                                                                                                                   25               70 20 30 3 743 68.7 50
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Table 4.2. Operational conditions and results of the most successful impregnation tests. 
         
Test 
     
T 
(ºC) 
       
P 
(bar) 
          
tCO2* 
(min) 
Depressurization 
Period          
(min) 
       
𝝆CO2 
(Kg/m
3
) 
Load
** 
% 
Impregnation
*** 
Duration 
of the 
process 
(min) 
11 40 110 30 30 684 0,07 7 60 
12 40 110 60 30 684 0,08 8 90 
* Contact period - Period in which sample, active principle and CO2 were in contact 
**Load = Impregnated ibuprofen/PMMA 
***%Impregnation=Impregnated ibuprofen/PMMA x 100 
 
The results allow considering that the GEI dental enables to impregnate the acrylic resins used in 
dental prostheses. However, only ibuprofen was tested, in other future studies, it is necessary to test 
other active principles, the required by orthodontists, as well as the respective operational conditions 
and the drug release profile inside the oral cavity, in order to obtain the maximum efficiency of the 
process. Therefore, the systems of impregnation with different active principle should be studied with 
more detail. The solubility of the drug into CO2, the ability of CO2 to penetrate the polymer and the 
partition coefficient of the drug between the dense gas and the polymer phase are important points to 
take into account during the development of GEI dental.   
4.3. Conclusion 
The results of the experimental tests allow considering that GEI dental achieves the proposed 
objectives, both for the extraction of MMA and the impregnation with an active principle in dental 
prostheses. The GEI enables extracting until 68.7% of MMA present in dental prosthesis in a process 
which lasts about 50 minutes. In addition, GEI dental allows the impregnation of ibuprofen with a 
%impregnation of 7% in a process with the duration of 60 minutes. To increase the %impregnation to 
8% the duration of the process must also increase to 90 minutes. 
The concept of the product was validated, however, it is not yet presented with the best characteristics 
to introduce into the dental market. Several studies should be done in order to develop the all 
potentialities of this product. The critical points of the GEI dental based on the experimental tests 
made are: 
a) The possible interaction of CO2 with the dye. Nevertheless, there is transparent acrylic without 
dye used in dental industry and, in addition, the composition of the dye is not the best to hu-
man use, probably the dye should be changed in the future, or even this technology could al-
low the impregnation of a safer dye. 
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b) The time of the process is an important point to be improved. The demand of dental care sec-
tor is the high efficiency in a shorter period of time possible.  
 
c) The efficiency of both processes could be improved, it is important to perform future tests in 
order to improve the processes. 
 
4.4. GEI dental components 
 
Since GEI dental will be transferred from the laboratory to the market, a new prototype was designed 
that should be mounted and tested. Comparing to the installation where the experimental tests were 
performed, the prototype must be simpler, automatized and with smaller dimensions. A preliminary 
design has been prepared for a future prototype in order to verify the technical feasibility of the GEI 
dental process and to estimate the costs associated to its production. The schematic diagram 
presented in Figure 4.3 was based on the functions of GEI dental, experimental tests performed and 
on the industry where the products are intended to be commercialized.  
 
 
 
I-4 I-6
 
Figure 4.3. Schematic diagram of the GEI dental apparatus (1-CO2 cylinder; 2- Chiller; 3- CO2 pump; 
4-Valve; 5- Pressure gauge; 6- Temperature gauge; 7- Rupture disk; 8- Relief valve; 9- High pressure 
vessel with internal stirring  and electrically thermostated with a heating jacket ; 10- stir plate 11- Filter; 
12- Automated Back-pressure regulator (BPR) with a heat exchanger; 13- Trap; 14- Chiller tubing; 15-
Compressor). 
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The entire diagram apparatus is described and discussed next. 
Liquid pump and chiller 
The apparatus comprises a liquid pump with a chiller to pump the CO2 into to the system to assure 
only liquid CO2 reaches the pump.  
Valves 
Two automated valves will be necessary, one before the vessel to regulate and control the input of the 
CO2 into the high pressure vessel, and other valve to control the output.  
High Pressure Vessel 
The high pressure vessel is jacketed with a heating mantle and must have the proper dimensions to 
put the dental prostheses inside without damaging it.  
Gauges 
The control of the temperature and the pressure will be ensured through controllers and sensors.  
Filter 
A filter is also required to ensure that the equipment will not clog, particularly BPR. In addition, in the 
recirculation of CO2 is also required a filters system. 
BPR 
The BPR has the function of limiting and precisely controlling the upstream pressure of the gas 
providing extremely high pressure stability to the system.  
Trap 
A trap is necessary in order to collect the MMA during the extraction process and to collect the active 
principle dissolved in the CO2 during the impregnation process. Chiller tubing allows maintain the trap 
chilled. 
Compressor  
The compressor permits the recycle of the CO2. 
As to avoid accidental overpressure, the apparatus proposed includes the installation of a rupture disk 
and a manual relief valve.  All the system will be connected by stainless steel tubings.   
The electrical circuit is not presented in Figure 4.3, but the installation will be fitted with an electronic 
circuit to allow automatic control. 
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In addition to the necessary equipment to perform the process, a metallic structure will be necessary 
to hold on the high vessel pressure, the pump with a chiller and the BPR automatized. Concerning the 
appearance and the design of the device, the entire setup should be coated with metallic plates with a 
principal open on the top. The mentioned overture corresponds to the opened vessel in order for the 
customer to put the dental prosthesis, in the case of extraction process, and in the case of the 
impregnation process, to put the dental prosthesis and the principal active, in the beginning of the 
process. The schematic apparatus presented in Figure 4.3 is enabled to perform both process 
extraction and impregnation. 
An informative table with the best operation conditions to extract MMA from dental prosthesis and with 
the best operation conditions to impregnate the dental prostheses with several active principles will be 
supplied together with equipment. 
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5. Market Analysis 
5.1. Market Outlook 
5.1.1. Potential Market Dimension 
 
In North America, Japan and Europe around 6% to 10% of the people are toothless and around 240 
million people have lost one or more teeth [51]. The dental market is dominated by Europe, United 
States (US) and Japan and account for more than 80% of the revenue generated [52]. The markets for 
dental implants in Europe being in a developing stage, the revenues for the base year were analyzed 
to be $0.79 billion and it is estimated to reach $1.94 billion by 2013 [53]. 
 
The tooth replacement has been of greater importance in modern society since it is associated to 
bone loss as well as to aesthetics [51]. Throughout the past 25 years, the dentistry sector has 
considerably developed. Most of these changes have occurred in the areas of technology, services 
made available and patient care. The main factors which were the ignition to the development of new 
dental materials and equipment were the increasing aging of population, enhanced treatments, 
improved awareness and high aesthetics [52].   
 
The restorative and preventive dentistry are the largest area of development and the segment in the 
global dental market that is growing the most is dental implantology. Although the current global 
economic scenario has impacted the growth of the dental implant market, the implant industry is very 
strong. Implantolagy segment is estimated an annual growth rate of 16.3% in the US from 2004 to 
2014 and 13.7% in the European Union (EU) from 2003 to 2013 [53-55]. 
 
Due to several European countries, particularly Sweden, Switzerland, Italy and Germany, having 
adopted at an early stage the dental implant technology, Europe is the largest market. Figure 5.1 
shows that US, North America (including Canada) represents less than a third of the dollar value of the 
dental implant market and Europe is the main agent of revenues of dental implant market [53]. 
Although there had been a recession, the European market has been recovering since 2009 and 
making considerable improvements in its revenues especially in 2010 [55]. 
 
 
Figure 5.1. Percentages of revenues by geographic region for the global dental implant market for 
2010 [53].  
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In the study of the market outlook it will be focused on European companies due to several reasons: 
 
a) Europe is the major revenue generator for dental implant manufacturers. 
b) Marketing the new product in European companies may be a less risky bet. The countries are 
closer geographically to Portugal, so the transportation is simpler and easier.  
c) Countries are more culturally similar and it has an analogous standard of living.  
  
All of the reasons referred above are important when developing a business in the dental industry. On 
the other hand, more risky and long-term entry strategies are in Brazil and other Latin American 
countries, US, Asia and Africa. Brazil and other Latin American countries have the disadvantage of 
being very protective, geographically distant, economically instable, and, last but not least important, 
the problem with copies and intellectual property. The US, besides being geographically distant, have 
a very competitive market and it requires large investments given its size. Asia has issues with 
intellectual property and a different culture. Lastly, Africa is a continent of very poor countries, and 
besides the underdevelopment of the dental industry, there probably are problems with intellectual 
property as well.  
 
With the purpose of making a simpler and more objective analysis, it was decided to choose eight 
European countries, including Portugal, as a representative sample of developed European countries. 
 
The estimative of potential market dimension comprises the observation of two important points: the 
number of people who use dental prostheses and the number of dental laboratories. The number of 
people with dentures allows having a global perspective of potential users of this product, in others 
words, the number of people who will use the product. On the other hand, the dental laboratories will 
be the companies which will possibly buy the device. So, the number of laboratories gives an 
estimative of who might be interested in buying the product. 
5.1.1.1. The United Kingdom case 
There are some essential data to estimate the potential market. Since the United Kingdom was the 
only country where detailed data were available on several indicators, it will be used to make 
projections on what is going on in other developed European countries. The United Kingdom seems to 
be a strong hypothesis to use as a bench mark country, because there are strong correlations of some 
demographic and health indicators among this country and other European countries.  
As it can be observed by tables presented below, there are several data with strong correlations 
among the United Kingdom and the European countries, such as the life expectancy (Table 5.1), 
population structure by age group (Table 5.2), and number of dentist/population (Table 5.3). The life 
expectancy of European countries presented is about 80 years (Table 5.1). The population structure 
by age group is also very similar among the European countries (Table 5.2). Considering the 
resemblances of the aforementioned indicators, projections of some essential data are possible to 
make in order to estimate the potential market. 
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Table 5.3 presents the number of practicing dentists in eight European countries. The countries can be 
divided in 3 groups based on the ratio number of dentist /population. One of the groups is represented 
by Portugal, United Kingdom and Austria which presents about 5 dentist by 10 000 people. Spain, 
France and Germany represent another group of about 7 dentists by 10 000 people. Finally, a third 
group is constituted by Italy and Sweden with the biggest proportion of dentist by population 
comparing to the other two groups of countries. Portugal presents an identical ratio of dentist by 
population to the United Kingdom which allows establishing strong correlations between the oral 
health care system of the United Kingdom and the oral health care system of Portugal.  
Table 5.1. Life expectancy at birth in Europeans countries [56]. 
 
Country Life expectancy at birth (2009) 
Portugal 79.6 
United Kingdom 
80.5 
Spain 81.8 
Italy 81.9 
France 81.6 
Germany 80.3 
Austria 
80.5 
Sweden 
81.5 
 
Table 5.2. Population structure by age group in 2010 [57]. 
Country 0-14 years 
(%) 
15-64 years 
(%) 
>65 years 
(%) 
Portugal 15.2 66.9 17.9 
United Kingdom 17.5 66.1 16.5 
Spain 
14.9 68.2 16.8 
Italy 
14.1 65.7 20.2 
France 
18.5 64.8 16.6 
Germany 
13.5 65.9 20.7 
Austria 
14.9 67.5 17.6 
Sweden 
16.6 65.3 18.1 
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Table 5.3. Number of practicing dentists in Europe [53]. 
 
                                         
Country Population 
(2011) 
                 
Number of  
practicing 
dentists   
                  
Number of 
Dentists/ 
Population 
 
Number of 
Dentists/ 
Population 
(per 10 000 
habitant) 
Portugal 10 636 979 5 000 
4.7E-4 4.7 
United Kingdom 
62 735 000 
34 100 
5.4E-4 5.4 
Spain 47 021 031 30 100 
6.4 E-4 6.4  
Italy 
58 126 212 
56 600 
9.7 E-4 9.7  
France 
64 057 792 
43 100 
6.7 E-4 6.7  
Germany 
82 329 758 
64 000 
7.8 E-4 7.8 
Austria 
8 217 280 
4 600 5.6 E-4 5.6 
 
Sweden 
9 041 000 
8 200 
9.1 E-4 9.1 
 
5.1.1.2. Dental prosthesis users   
Table 5.4 shows the percentage of people with dental prostheses divided by two age groups of five 
European countries in 1991. Although the data are of about twenty years ago, they give an idea of the 
population with dental prostheses in European developed countries. The age group 35-44 shows 
reduced percentages of people with dental prostheses (less than 1%). On the other hand, the age 
group >65 is clearly where most of the dental prosthesis users appear in all countries presents. The 
United Kingdom presents high percentage of people with dental prostheses (67%) compared to other 
countries (about 20%) in the age group >65. 
 
Table 5.4. Percentage of people by age group with dental prostheses in European countries [58]. 
 
 
Country 
 
Total 
Population 
Percentage of people by 
age with dental prostheses 
(1991) 
  35-44 >65 
United Kingdom 
62 735 000 4.0 67.0 
Italy 58 126 212 
0.3 18.0 
Germany 82 329 758 
0.4 27.0 
Sweden 
9 041 000 
1.0 20.0 
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Table 5.5 shows some data of Dental Health Survey in 2009. Even though the referred survey does 
not include the population of Scotland, it was considered that the data shown represent United 
Kingdom. The percentage of women (17%) and men (21%) with dentures is very similar, apparently 
the use of dentures is regardless of sex. The proportion of adults with natural teeth and dentures 
varies by the age group. The United Kingdom population with 16-44 years is the age group with 
natural teeth only (97%) and with a low percentage of people with dentures (3%). Accordingly, the age 
group 16-44 will use our product less. On the other hand, the age group >75 presents the lowest 
percentage of natural teeth only (29%) and the highest in users of dentures (70%). Following next, the 
age group 65-74 presents a percentage of 55% with natural teeth and only 45% are dentures wearers. 
The age group in which this product will have more users is from 65 up.  
 
Table 5.5. Percentage of people with dentures by age of England, Wales, Northern Ireland (2009) [59]. 
 
  
Natural 
teeth 
only  
(%) 
 
Natural 
teeth and 
dentures 
(%) 
 
Edentate
1
 
with 
dentures 
(%) 
 
Edentate, 
no 
dentures 
(%) 
 
With 
dentures 
(%) 
Age      
16-44 
97 3 0 - 3 
45-54 
88 11 1 0 12 
55-64 
71 23 5 0 29 
65-74 
55 30 15 0 45 
>75 
29 37 33 1 70 
All 
81 13 6 0 19 
Men 
83 12 5 0 17 
Women 
79 14 7 0 21 
 
According to Dental Health Survey, in 2009 about 19% of the population in the United Kingdom is 
dental prosthesis users (Table 5.5). The strong correlations of some health indicators verified in Tables 
5.1, 5.2, and 5.3 allow considering that Portugal and other European countries may have similar 
numbers of dental prosthesis users. Therefore, it is considered that about 19% of the population of 
European developed countries uses dental prosthesis and so they will be potential users of the 
product.  
5.1.1.3. Number of dental laboratories  
The ratios presented in Table 5.6 allow having an idea about the number of dental laboratories by total 
Population in developed European countries. Some differences between countries can be observed. 
In the United Kingdom’s case, there is about 5 laboratories per 100 000 habitants, while Germany, 
Austria and Sweden present about 4 laboratories per 100 000 habitants. Among the countries shown 
in Table 5.6, the United Kingdom is the country with more laboratories by people. There is a significant 
                                                          
1
  Edentate, that is having no natural teeth.   
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number of dental laboratories in European developed countries and with a similar proportion of the 
dental laboratories per capita. So, this technology has a high market size. 
 
Table 5.6. Number of dental laboratories in European countries. 
 
Country Total 
Population 
Number of dental 
laboratories 
Number of dental 
laboratories/Total 
Population 
Number of dental 
laboratories/Total 
Population           
(per 100 000 
habitants) 
Portugal 10 636 979 
333
2 
3.1E-5 3.1 
United Kingston 
62 735 000 
2 000
3 
5.3E-5 5.3 
Germany 82 329 758 8 600
4 4E-5 4 
Austria 8 217 280 6575 4.1E-5 4,1 
Sweden 
9 041 000 583
6 3.7E-5 3.7 
 
5.1.1.4. Portugal’s Case 
The GEI is a Portuguese technology. For this reason, Portugal will be the market test for the 
implementation of the GEI dental in the market. The following section is intended to discuss about the 
market size in Portugal. 
 
In Portugal there is not any study about the quantity of Portuguese population that uses dental 
prostheses. Therefore, it was decided to collect data from a questionnaire applied to the Portuguese 
population. The questionnaire was conducted online and it is presented in Appendix 4. The sample 
comprises 143 people randomly chosen. As it is possible to observe in Figure 5.2, about 21% of the 
Portuguese population uses dental prostheses. The result of the online questionnaire reinforces the 
previous projection from the United Kingdom’s case. 
 
                                                          
2
 Number estimated. 
3
 Source: Dental Laboratories Association of United Kingdom (2011). 
4
 Dental laboratories and companies in Germany in 2000. Source: www.kzbv.de 
5
 Dental laboratories and companies in Austria in 2003.  Source: www.kzbv.de 
6
 Source: Malmö University Faculty of Odontology Department of Prosthodontics Sweden (2011). 
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Figure 5.2. Proportion of Portuguese population using dental prosthesis (data collected from online 
questionnaire). 
According to Instituto Nacional de Estatistica (INE), the number of enterprises by Economic activity 
and Employment size class service with activities of dental practice in Portugal are 6 807. This is the 
unique information about dental industry in Portugal, however it is very limited because activities of 
dental practice include dentistry, prosthesis technicians, dental clinics and other activities related to the 
dental industry in general and not only dental laboratories.  
Due to the absence of data about the number of dental laboratories in Portugal, a projection of the 
number of dental laboratories in Portugal was made, considering once more the United Kingdom’s 
case. According to Dental Laboratories Association of the United Kingdom, the number of laboratories 
in this country is 2 000 (Table 5.6).  As it is possible to observe in Table 5.6, the population of Portugal 
is about 1/6 the population of United Kingdom. The projection is made based on the proportion 
between the United Kingdom’s population and Portugal’s population. Therefore, the estimated number 
of dental laboratories in Portugal is 333. 
As a conclusion, about 21 % of Portugal’s population possibly is dental prosthesis wearers and they 
can be potential users of this product. The number of Portuguese companies which might be 
interested in buying the product is about 333 dental laboratories. 
5.1.2.  The STP Process  
The STP process is the method by which the markets are subdivided into different segments. This 
process refers to three activities which are segmentation, targeting, and positioning, and the next 
section is structured around these key elements [60].  
5.1.2.1. Segmentation 
The market can be divided into distinct groups of customers with different needs, characteristics or 
behaviors, who can need distinct products or marketing mix [61].    
 
21% 
79% 
Portuguese population
with dental prosthesis
Portuguese population
without dental
prosthesis
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The market is business to business (B2B) in which the client is different to the final customer. Clients 
are the companies of dental laboratories and the final customer are the dental prosthesis wearers. 
Although the final customer has the necessity, the dental laboratories are the ones that will buy the 
product. The company will be a supplier of equipment to the laboratories. The final product are the 
improved dental prostheses that will be used by the patient, so GEI dental only improves the final 
product. Therefore, the market is B2B and not Business to customer (B2C) because the company will 
sell to another company (laboratories) and not to the final customer, the patients. 
 
The study of market segmentation will be based on characteristics of dental laboratories.  
 
Segmentation by interest in the innovation 
Innovation is an important feature to segment the market because the product is an innovative 
technology applied to dental prostheses. So, it is important to segment the market according to the 
company’s interest in innovation. 
There are companies with more modern equipment and materials. These companies are equipped 
with CAD/CAM systems and they are always interested in the latest news. This type of company, 
besides manufacturing the prostheses, is usually involved in investigation, it has the most modern 
equipment, and it uses the techniques and materials of the last generation. Other companies are more 
traditional and use traditional manual techniques, less modern equipment and usually are not involved 
in research.  
Segmentation by the size of dental laboratories 
The size of dental laboratories is an important variable to segment the market. It is important to 
distinguish the companies with a large size from the ones with a small size. The companies with a 
large dimension are companies with various workers, with a high numbers of dental prostheses 
manufactured per month, as well as a large number of laboratories. On the other hand, the small 
companies have a reduced number of laboratories or even none in the European countries, and have 
a low number of dental prostheses manufactured per month. The companies with large dimensions 
have the advantage of having a payback in a shorter period of time, since they have more prostheses 
orders per month. The mentioned advantage shows that the purchase of GEI dental will be more 
attractive to the companies of a large dimension. 
Another important feature to take into account is the number of dental laboratories that each company 
has in Portugal, since Portugal is the country used as a test market for this product. 
Segmentation by location 
The market can be segmented according to the geographical location of laboratories. The 
geographical location is an important feature because, as mentioned above, the characteristics of the 
markets are different according to their own geographical location.  
37 
 
 
As it is a Portuguese technology, at the beginning the Portuguese market will be explored, thus 
Portuguese laboratories are being focused. The next step is entering into the European companies 
because it is geographically closer, it is culturally similar and it has an analogous standard of living. 
Besides, Europe has more guarantees concerning intellectual protection compared to other locations, 
such as Africa or Asia.  
 
One criterion that it is considered important to segment the market is the headquarters/nationality of 
the companies.  This criterion is important because, although the companies can have laboratories in 
many countries, the headquarters is where most of the important functions of an organization are 
coordinated and usually is where the innovations are developed. 
 
Segmentation by financial soundness 
 
The financial soundness is another important point to take into account. There are companies with 
stable and positive financial conditions. On the other hand, there are other companies that do not 
present the best financial situation. So, it is important to pay attention to this parameter because it 
helps to evaluate which of the companies have a favorable financial condition to invest in this new 
product.   
 
The financial soundness may be related to the maturity of the businesses, in other words, the older 
companies could possibly have a more stable and prosper financial situation. In dental industry there 
are companies founded about ninety years ago and other for three years. And in some cases the 
financial condition, the credibility and the confidence that the companies transmit are related to the 
lifetime of the firm.  
5.1.2.2.  Targeting 
 
Market segmentation reveals the firm’s market segment opportunities. The firm has now to evaluate 
the various segments and decide how many and which segments can serve the best [61].   
 
The evaluation of marketing target was made by the study of the following features of the companies 
existing on the market receptivity to innovation, laboratories in European countries especially in 
Portugal, a large number of laboratories and financial soundness.  
 
An important feature that companies should have is the interest in innovation. Usually these 
companies have most modern techniques and equipment because they have the concern for 
supplying their customers with the best and more advanced products. On a regular basis, the largest 
companies are the most involved in research and are those that require the latest technologic 
advances.  
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The company having laboratories in Europe and especially in Portugal is another important required 
point because Portugal is the market test. 
 
A large number of laboratories is another aspect required. Companies which have a large number of 
laboratories in European countries, and especially in Portugal, are the most interesting to focus on. 
Companies with a considerable number of laboratories probably require more units of devices.  
 
The financial situation of companies is an important characteristic to pay attention to.  A criterion to 
decide which companies we will focus on is companies’ financial soundness. The financial 
soundness can be considered as a guarantee that companies have capital to invest and are in a 
favorable financial situation. The referred criterion will be evaluated based on the years of the 
companies in the market, since it was not possible to ascertain the financial situation of the majority of 
the companies.  
 
A study about dental laboratories worldwide is made with the purpose of having a global view about 
dental companies of the entire world and how they suit in the targeting criterion.  In Appendix 6 a list of 
several dental companies, evaluated according to the targeting criteria, is presented. Even though 
most companies are local laboratories with only one laboratory, there are also leading laboratories 
worldwide with networks of dental laboratories across the world, such as, Nobel Biocare, MDH, Maló 
Clinic, Precision Dental Studio, Sun Dental Laboratories, among others.   
Despite the majority of dental laboratories in Portugal being local, with a small dimension and usually 
only a single laboratory and not a network of laboratories, it is possible to verify the existence of 
influential companies in the dental industry in Portugal. Some examples of companies with a strong 
presence in the Portuguese and European market are MDH and Malo Clinic. The mentioned 
companies have interest in advanced and innovative technologies In addition, there are small 
Portuguese dental laboratories, such as Orallab, which have interest in innovation and to give a high 
quality service to their customers. Therefore, the mentioned companies are examples of the target 
market for GEI dental.  
5.1.2.3. Positioning  
The differentiated value created to the target segments and the product’s position must be defined by 
the company.  The product’s position can be defined as the way the product occupies in the 
costumers’ minds [61]. Positioning allows distinguishing a product from another and provides to 
potential clients a reason to buy those [60]. 
 
The GEI dental appears in the market as an innovative device which uses scCO2 to improve 
properties of one of the most used materials in the manufacture of dental prostheses. 
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The technology does not change the properties of manipulated material, so the composition of 
biomaterial used in the prosthesis is not altered. In this way the attributes, such as biocompatibility 
are not affected after the prostheses are manipulated with GEI dental.  
The health care involves a series of restrictions and rules to assure the safety of the patients. Due to 
the dental prostheses being a medical device, it is important to guarantee that it has not any adverse 
effect and it does not present any kind of risk to the patients’ health. The GEI technology presents the 
advantages referred in the section of the technology description, which makes the association of this 
technology to health sector conceivable. Therefore, since the technology does not present any risk to 
the health, it is considered a safe product. 
The clean technology belongs to a class of equipments that can promote sustainable management 
of resources. The conditions of operation are mild, in other words, they allow working at relatively low 
temperatures suitable for thermally labile substances. Nowadays the waste produced and 
accumulated from the chemical process is a significant global concern. So, for this reason, cleaner 
technologies are an area of growing interest worldwide.  
The GEI dental is presented as a versatility product, besides having two distinct functions. On the 
one hand, it allows the extraction of residual monomers, the MMA, and, secondly, it allows 
impregnating the prosthesis with an active principle. The versatility can be related also to the fact that 
it can be impregnated with different active principles which gives different properties to the dental 
prostheses. The active principles present a variable range of possible utilizations, such as anti-
inflammatory or a substance to good breath 
The product will be positioned as a device that adds value to the dental prostheses and it will also 
respond to a necessity of dental prostheses. The extraction of MMA was suggested by the dental 
professionals addressed, as being a problem of acrylic resins used in orthodontia, so the GEI dental 
responds to a necessity of dentistry industry. On the other hand, the possibility to impregnate dental 
prostheses with an active principal confers an additional value to dental prostheses. A big concern of 
oral health care are the infections, which are a common problem. The GEI dental can be considered 
as a device aimed at the prevention of dental diseases or in other cases as a treatment. 
Another aspect to take into account is the equipment design. The device will be manufactured in order 
to have a practical and simple manipulation, because it will not be used by a supercritical fluids’ 
specialist. 
The product is clearly noticeable and it will be requested by its possible customers due to the follows 
aspects: 
 Innovative product  
 It does not interfere with the dental prostheses characteristics, including  
biocompatibility  
 It is safe 
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 It is environmentally friendly 
 It presents versatility 
 It meets a need of the orthodontia 
 It adds value to the dental prostheses 
 The manipulation is practical and simple 
 
All the characteristics mentioned above allow the product to be presented to the dental market as a 
high quality new device for improving the dental prostheses.  
5.2.  Competitors 
Although there are several researches to improve the properties of acrylic, there is not yet any device 
in the market to change it or add the attributes that the GEI dental proposes. 
Dental industry presents a wide scope of materials used in dentistry, which may be used, for example, 
in the production of dental bases, restorations, impressions and prostheses [52]. However, it is 
possible to divide them into three main groups: acrylic (polymers), ceramics and metals. 
The dental prostheses should be prepared for a long period contact with oral tissues and fluids. Some 
key elements must be taken into account in its fabrication, its components must have characteristics 
that assure a safety profile and should not be either allergenic or carcinogenic [62].  
Polymers 
Since acrylic polymers are the mostly used in prosthodontics, the acrylic was considered a 
representative of polymers.  The main attributes of acrylic resins are their easy processing, low cost, 
lightweight, and color matching ability. On the other hand, the material is low in strength, brittle, low in 
thermal conductivity and it has been shown to be cytotoxic [63]. In the field of dentistry, the use of 
acrylic has a very wide range of applications. These include the use in dental impressions, the use as 
a veneer in crowns, in temporary procedures, such as bridges, the use in dentures, in implants and in 
mouthpieces.  
Ceramics 
The ceramics has many positive characteristics, such as high biocompatibility, the color and 
translucencies are similar to natural tooth, and it is suitable to work in dental bridges and implants [54]. 
However, this material also presents a low impact resistance, properties difficult to reproduce and 
difficulties in processing and fabrication [64]. Ceramics is mainly used for inlays, crowns, fixed bridges 
and aesthetic veneers.   
Metals 
Prostheses are often constructed using metals, due to their characteristics, such as hardness, 
strength, stiffness, durability, corrosion resistance, and bio-compatibility [62]. The referred group of 
materials comprises a large variety of options and the type of metals most commonly used in dentistry 
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is the amalgam, gold alloys and base metal alloys. Nevertheless, the color of these materials is not 
similar to natural tooth color. The metals are used in primarily for crowns, fixed bridges, and partial 
dentures [52] 
The materials described above represent a general view of the dental materials. There is a demand in 
the improvement and innovation of dental materials. The mentioned materials are available in the 
market throughout supply companies of dental laboratories. There are companies which are dedicated 
exclusively to the sale of metal to dental implants. On the other hand, there are companies that sale all 
types of consumable materials to dental laboratories including acrylic and ceramics.  
 
5.2.1. Performance Map 
 
As mentioned above, it is possible to divide dental materials in three main groups: acrylic (polymer), 
ceramics and metals. GEI dental is a technology applied to the acrylic, so in Table 5.7 the performance 
of GEI dental refers to the acrylic after being manipulated with the technology. The following map 
compares the performance of dental materials according to some attributes.  
 
Table 5.7. Performance Map: Attributes vs Competitors.  
 
 GEI dental 
(Acrylic) 
Acrylic Ceramic Metal 
alloys 
 
Avoid infections 
 
    
 
Avoid allergic  
reactions  
 
    
 
Avoid malodor 
 
 
    
 
Esthetic 
  
    
 
Easy manipulation 
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Resistance 
 
   
 
 
 
Price 
 
 
    
Legend: Green        : High performance; yellow       : Medium performance; Red      : Low performance 
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Avoid infections: The risk of infection is an important feature to take into account in this type of 
devices. The GEI dental will be allowed to reduce risks of infection, as well as it treatment.  
 
Avoid allergic reactions: The material which presents a biggest risk of allergic reactions is the 
acrylic. The GEI dental can decrease the referred risk, since it allows the extraction of the MMA. 
 
Avoid malodor: The malodor is associated to acrylic prosthesis. The GEI dental is a good option to 
end the problem and it will allow the acrylic to become more competitive against the other competitors. 
 
Esthetic: The esthetic is another important feature and metals are a less esthetic material compared 
to others.  
 
Easy of manipulation: One of the advantages of acrylic is the ease and simplicity of its manufacture. 
On the other hand, the ceramics and metals require a complex manipulation, especially the metals. 
The GEI dental does not change this attribute of acrylic. 
 
Possibility to use in many applications: The acrylic is one of the most used materials in dentistry 
with a high range of possible applications. Therefore, the acrylic presents more possibilities of use 
compared to the metal and ceramics.  
 
Resistance:  The resistance of material refers to the facility of material break. Metal presents high 
tensile and fatigue strength compared to ceramics and acrylic resins. However, ceramics presents 
also a high resistance capacity, so acrylic is the most susceptible material to be broken.     
 
Price: The acrylic is the cheapest material comparing to metal and ceramic. Although the GEI 
technology will turn acrylic more expensive, the technology will bring other important benefits. 
 
Although the acrylic has some limitations, it presents important attributes which made it one of the 
most used materials in dental prostheses’ manufacture. As a consequence, there is a significant 
research about it with the purpose of improving its properties. The GEI dental allows improving some 
disadvantageous characteristics of acrylic without changing the advantageous ones. In conclusion, the 
technology could permit less risks of infection, less risks of allergy, as well as a good breath. 
Therefore, the acrylic then manipulated by GEI dental is a stronger product compared to its 
competitors, because it provides important features to the dental prostheses, which will allow high 
comfort and safety to the patient. 
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5.3. Supply chain  
5.3.1. Value chain 
The value chain of the dental industry is presented next in Figure 5.3 and comprises suppliers, 
distribution companies, dental laboratories and dental clinics. 
 
 
a 
Suppliers 
 
 
 
 
 
Figure 5.3. Value chain of dental industry. 
 
Suppliers 
There are two types of products which the laboratories order to the companies that manufacture the 
dental prostheses, the consumable materials and equipment. The dental consumables refer to all 
materials and consumables used by the dental professionals in their daily work, such as acrylic, 
metallic alloys, ceramics and others. The companies which supply laboratories with acrylic and 
ceramics are companies specialized in these products and there are a considerable number in 
Portugal. Although the companies which supply laboratories with metallic alloys are big metal 
manufacturing companies, they have a small department directed to dental laboratories. The dental 
equipment comprises large and small equipment. As an example of large equipment, there are 
autoclaves, sterilizer and digital imaging system. Considering small equipment, there are amalgam 
removal systems, handpiece cleaner, and ultrasonic cleaners.  
 
Distribution 
In this point the value chain can be different, in other words, it can have a distribution company only 
responsible for transportation and marketing the product (Figure 5.3) or, on the other hand, it can 
present supply companies doing their own transportation and marketing (without a distribution 
company in the value chain). Distribution will be analyzed in detail in section 5.3.3. Distribution 
channels 
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Laboratory   
The laboratories are responsible for manufacturing the dental prosthesis from the mold of the patient 
provided by dentists. Each prosthesis is made specifically for each patient from the mold, and the 
techniques of dental laboratories make the shape with the appropriate materials and the all esthetic 
part of the prosthesis, until its complete fabrication, which will be used for the final customer.  
 
 
Clinic 
In the dentist clinic, the dentists are responsible for choosing the most appropriate type of prosthesis 
to the patient and make the mold. After the prosthesis being made by laboratories, the dentists are 
responsible for putting the dental prosthesis in the patients’ mouth and make the final adjustments, in 
order to the prosthesis to be well adapted. 
5.3.2. Potential suppliers 
The potential suppliers will be the companies which will sell the necessary components to assemble 
the GEI dental device. 
 
The GEI dental will be constituted by a high range of materials, from valves, high pressure vessels to 
electronic material. This kind of material is all of high pressure, so it is important that it presents high 
levels of quality in order to GEI dental to execute its functions without any problem. The majority of 
materials can be ordered through companies that commercialize supercritical fluid equipment. Each 
supplier is selected according to the meeting of following criteria: quality of materials, price and trust.  
 
Besides, the company only being responsible for the proper assemblage of devices presents a high 
external dependence level, so the choice of suppliers and the connections created are very important 
to the good functioning of the company. The purpose is to make advantageous partnerships with the 
companies which sell the aforementioned products in order for the company to honor its commitment 
without unnecessary spending.  
5.3.3. Distribution channels 
As previously mentioned, the company will focus on the European market, so this section will take into 
account the European distribution channels. 
 
An essential point to consider is how the product gets to the client. According to the CBI Market 
Information Database, it is possible to define two main trade channels through which dental products 
are distributed. The different trade channels are direct distribution and distribution through an 
intermediary [65]. 
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Direct distribution  
 
If the product is delivered to an end-user, such as dental laboratory is considered direct distribution. 
The purchases for healthcare professional’s facilities are increasingly made through websites, such as 
the Global Health Exchange (http://www.ghx.com), which were developed by the major players in the 
market. Likewise, the Association of Dental Dealers in Europe (ADDE) and International Federation of 
Dentists (FIDE) started an initiative to develop an e-commerce site for the industry.  
 
Distribution through an intermediary   
 
Distribution through an intermediary is when distributors intervene as middle-men. In terms of product 
knowledge, the dental distributors are highly specialized and usually have a large network given its 
development and experience in dental industry.  Among distributors and dental specialist, user groups, 
and technicians responsible for maintaining the equipment, there is a high level of communication and 
cooperation.  CBI Market Information Database recommends for developing countries suppliers that 
distribute through an intermediary. They consider that direct distribution is very difficult for newcomers 
to the market for various reasons, such as company size, service, personal relationship, reputation 
and activities. The sites known as dental depots are used in many of the European markets to sell 
dental equipment to dental practitioners via distributors. Dental depots stock has a wide range of 
products and sells their products directly to the public and private dental practices [65].  
 
5.4. Market trend, Growth potential  
5.4.1. Potential value of market 
The final customer of GEI dental are the dental prosthesis users. Following next, a global view of 
dental wearers in the last 12 years and projections until 2020 is presented. 
According to the U.S. CENSUS Bureau International Database and GSK Incidence Data, in the last 
twelve years there was a growth about 15% of dental wearers (Figure 5.4). In addition, it is expected 
that in the next eight years dental wearers will grow about 20%. This growth of dental wearers through 
time and the prediction that it may continue to increase can be explained by several reasons. They 
include a demographic shift towards an aging population, along the desire to retain tooth structure 
later in life, an increased desire for aesthetics and the growing concern and consciousness about oral 
health [66]. 
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Figure 5.4. Evolution of global dentures wearers over the years [67]. 
 
5.4.2. Growth rate of industry 
 
The fast growing of the dental industry sector is presented in Figure 5.5. From 2006 to 2013 the 
compound annual growth rates (CAGR) for the dental implants market in Europe is estimated to be 
13.7 per cent [55]. 
 
 
Figure 5.5. Revenue forecasts for the total European dental implants market from 2003 to 2013 [53]. 
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The Figure 5.6 presents a global dental consumables market analysis by product segment, 2008-
2015. The restorative and cosmetic supplies, materials, and prosthetics is the product segment with  
the largest revenues, in 2010 was valued at $9 billion and in 2015 is expected  to reach $11.7 billion. 
In 2010 the global dental consumables and prosthesis market was valued at $15.9 billion, while in 
2015 the market is expected to reach $18.5 billion [68]. 
 
Figure 5.6.Global dental consumables market analysis by product segment, 2008-2015 [68]. 
 
The dental market presents a solid growth determined by a number of factors. Some of them are 
already mentioned above when the growth of dental prostheses wearers is explained, because the 
growth of both dental prostheses wearers and dental market are related. In addition to these factors, 
there are others, which include the growth of available profits, a desire to meet dentists and patients’ 
needs, a bigger concern for oral preventive care, including the durability of natural teeth, and an 
interest in technological development [65-66]. This last item, technological development, represents a 
great benefit to global dental market, since it is an important tool for the dentists to offer a higher 
quality treatment to their patients. The technological innovation of the dental market has been growing 
considerably compared to the dental market in general, which is still expected to continue in the future 
[66]. 
5.5. Key Stakeholders 
Regulatory authorities  
The commercialization of the product can be influenced by the product’s certification and approval of 
certain authorities. The accreditation of Infarmed in Portugal is crucial to marketing any health product 
in Portugal, moreover it is important to obtain the CE marking. 
The suppliers and distribution companies 
The suppliers and distributors are essential partners in order to deliver a high quality product to the 
customer. Establishing good partnerships with suppliers is crucial to guarantee the components which 
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constitute GEI dental, to assembly the device on time, in order to meet deadlines. The choice of the 
distribution company which will represent the GEI dental is another significant point to take into 
account because it is important to have a trust, efficient and quality transportation and divulgation 
service of this new product to the international dental market. 
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6. Commercial strategy- Legal aspects 
6.1.  Intellectual property 
 
The product came up from the application of the technology with the following patent-PT 103360 A. 
The main features of the patent are presented in Table 6.1 and the main steps of the patenting 
process are presented in Table 6.2. The patent PT 103360 A has only a Portuguese protection. 
 
Table 6.1. Patent features.  
Publication number PT 103360 A 
International classification B29B 15/10 (2006.01) C08J 3/20 (2006.01) 
Coordinator IBET (Instituto de Biologia Experimental e 
Tecnológica)         
 
 
Inventors 
Catarina Maria Martins Duarte 
Ana Rita Cruz Duarte 
Ana Vital Morgado Marque Nunes 
Carlos Tiago Baioneta Soares Cravo 
 
 Table 6.2. Steps followed in patenting process.  
Filing date for National Patent with Instituto Nacional de 
Propriedade Intelectual (INPI) 
2005.09.28 
Publication of filing National Patent PT 103360 A 2007. 03.30 
 
Current situation 
 
Due to the high cost of the patent’s maintenance, the payment was cancelled and as a consequence 
the patent expired. Although the current project had started based on this patent, it presents 
substantial differences from the idea described in the patent. As a result, the GEI dental will require a 
new patent. 
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Possibility of a new patent 
 
The protection of an idea is important to avoid copies, however the patenting involves a high cost 
initially and also for maintenance of the patent. In addition to the process of patenting being 
expensive, the compliance of restricted criteria is necessary. Licensing an idea is a complex and not 
always successful process. The three main criteria to consider patenting an idea are the following:  
 
New:  the idea should never be mentioned in patents, scientific articles or oral presentations.  
 
Inventive activity: It is not obvious to an expert in the area. 
 
Industry application: it should be reproducible. 
 
Firstly, in order to guarantee the novelty of the idea, an intense search was made related to the 
patents or scientific articles which can be compromised at the possibility of patenting our idea. 
 
Impregnations and extracting methods using scCO2 have already been described in various patents 
and articles. The possibility of patenting the idea appears in the application given to the technology, 
and not in the technology itself, because the novelty is the application and not the process. In addition, 
a new and sophisticated prototype should be created. The results of the survey about extraction of 
MMA by scCO2 from dental prostheses or the impregnation with active principle are positive because 
no scientific article was found nor any patent reporting to it specifically. However, there are studies that 
have reported the use of scCO2 in the extraction of MMA from PMMA used in other products and not 
used in dental prostheses, and there are even more scientific articles reporting scCO2 as 
polymerization of the PMMA medium. Therefore the first criterion, the novelty of the idea, may have 
some difficulties to be fulfilled. 
 
Concerning the second criterion, some barriers may be found. There is a scientific article, “Process 
design for the removal of residual monomer from latex products using supercritical carbon dioxide” 
which can question the performance of the second criterion. The article describes the use of scCO2 to 
extract MMA from the latex [69]. While the article refers to latex products, experts would consider it 
logical that the process can be adapted to dental prostheses, since the polymer (PMMA) is the same. 
The same happens with the impregnation of dental prostheses, because there are already scientific 
articles which report impregnation of PMMA using scCO2. Even though no patent or scientific article 
specifically reports the extraction and the impregnation of dental prostheses, there are already articles 
about MMA extraction from PMMA and about impregnation of PMMA using scCO2 but in different 
products that are made of PMMA. So, an expert would be considering it logical that the process could 
be adapted to dental prosthesis, since the polymer is the same. 
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Finally, reproducibility is also assured since it is possible to improve the prototype in a way as to turn 
technology into a more easily manipulated and more automated system in order to commercialization 
to be possible. Therefore, the invention will have industrial applicability.  
 
In conclusion, besides the high cost of the patenting process, there is a high probability of the criteria 
not being achieved. Furthermore, by the scenario presented it might be difficult to patent the idea. 
However, there will be the possibility to patent the final product, since its characteristics are completely 
new. Nowadays there is not any device enabled to remove MMA, after the preparation of the dental 
prostheses, from the acrylic or impregnate dental prostheses with therapeutic active principles. So, 
after the development of the GEI dental, which includes obtaining the best operation conditions’ for 
both the processes and having different impregnation systems of active principles, it is expected to 
have a new product which can fulfill all the criteria referred above in order for the GEI dental patent to 
be possible. Therefore, it is expected that it may be possible to patent a prototype of the GEI dental 
device enabled to extract MMA from the acrylic used in dental prostheses and to impregnate dental 
prostheses with different active principles and the respective drug release profile well known. 
6.2. Regulatory concerns 
The GEI dental is a device by which dental prostheses are manipulated, in other words, the device will 
change in a certain way some dental prostheses’ characteristics. Dental prostheses are a class IIa 
medical device (medium-risk devices), consequently it is exposed to several restricted rules and 
norms. In addition, this product is considered a medical device because it involves active drug 
administration systems which will be used for human beings for the purpose of the prevention and the 
treatment of diseases. The manufacturing of GEI dental should be done in a way as to guarantee that 
these restricted rules are maintained.  
In order to offer a proper treatment to the patients, it is crucial to consider the safety of the medical 
devices. So, there are entities responsible for checking and assuring the safety features of several 
medical devices and for guaranteeing that the untested or the inadequately tested devices do not 
enter the market [70]. The certificates and rules which GEI dental should achieve to be 
commercialized will be presented next. 
EMEA 
All the information that will be mentioned following can be found at the European Medicines Agency 
(EMEA) homepage. The evaluation and supervision of medical products for human or animal use is 
the responsibility of the EMEA which is a decentralized body of the EU. The aim of this agency is 
protecting human and animal health. In order to enter in the EU market, medical devices must obey 
the Directive 93/42/EEG and have the CE marking. The producers of drugs and medical devices who 
want to commercialize their products in the EU must only submit one single marketing authorization 
application to the EMEA, in which the documentation should be written in English, French or German. 
An enterpriser who does not have the company registered in an EU country should designate a single 
authorized representative in the EU [71].  
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ISO  
A standard for quality management system for medical devices called ISO 13485 was developed by 
the International Organization for Standardization (ISO).  This standard is founded on ISO 9001:2000 
and provides guidelines to the companies to implement and maintain a quality management system. 
In many countries this standard is considered as a way of achieving Good Manufacturing Practice 
[71]. In deciding to deploy ISO, the company must hire a company that will conduct a certificated audit, 
to verify if the company meets the requirements of the standard. This certificated company is an 
independent entity and authorized to conduct audits.  
 
IEC 
Furthermore, there is also regulation related to electrical equipment. The international organization 
responsible for the preparation and publication of International Standards for all electrical, electronic 
and related technologies is the International Electrotechnical Commission (IEC). The IEC 61293 is an 
international standard, which establishes minimum requirements and general rules to electrical 
equipment and other characteristics allowing the appropriate and safe installation of electrical 
equipment [72]. 
 
CE marking 
The requirements to obtain CE marking for all medical devices are mainly a technical documentation, 
a risk analysis, a proof of compliance with the essential requirements of the directive and a product 
related declaration of conformity issued by the manufacturer.  The non-sterile class I devices without 
measuring function are the only ones that do not need the involvement of a Notified Body. The 
mentioned devices are marked by the producer’s only responsibility with the CE marking without a 
number. On the other hand, all the other devices need the certification by a Notified Body before the 
manufacturer can put the CE marking in combination with the number of the Notified Body on the 
device. The manufacture can choose different certification routes, depending on the device class [73]. 
In addition, due to the equipment being electrical, CE marking is required to electrical equipment.  
 
Infarmed 
Infarmed is the regulating entity in Portugal. According to the official Infarmed website, the entities 
holding facilities engaged in the manufacturing of medicine and health products are under the 
industrial licensing in accordance with the applicable law- Decree-Law nº 209/2008 of 29 October, 
Decree nº 8/2003, 11 April, Ordinance nº 464/2003, 6 June. The entity coordinating the industrial 
license is the Ministry of Economy and Innovation with Infarmed participating as a consulted entity in 
the field of manufacturing medicine and health products. 
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7. Business Model 
The business model describes the way a company generates revenues by specifying its position in the 
value chain [74].  
 
7.1.  Value Preposition  
 
The acrylic resins are one of the materials mostly used in dentistry. However, it presents certain 
limitations, and as consequence the referred material has been widely studied in recent years with the 
purpose of improving it. The mentioned material is a polymer PMMA and its monomer is MMA. One of 
the main features of the material is releasing MMA when the patient is using the dental prosthesis, 
which has adverse effects (Chapter 3 Market Pain). This feature is a dental professional’s concern 
about the use of acrylic in dentistry, and it was even referred by one of the dental professional 
addressed (Appendix 2). Another important feature in oral health care are the infections. Very often 
dental prosthesis users suffer infections and other characteristic diseases associated to dental 
prostheses use. In addition, malodor is another problem associated to the denture users and a good 
breath is a characteristic which everyone desires.  
 
The GEI dental is presented as a solution to solve the above problems in dentistry. The technology 
provides both an improvement of acrylic properties and adds favorable characteristics to dental 
prostheses. In addition, this product belongs to a new generation of green products, which is a very 
important aspect, allowing the association of dental industry with supercritical technology or even 
presenting supercritical technology to the dental industry. 
 
7.2.  Entry in the market: Value chain 
 
The GEI dental will enter in the market through the creation of a start-up, Sustainable Solutions (SS). 
The company will be responsible for manufacturing the product and for maintaining the equipment 
after the acquisition by dental laboratories.  
 
The various components for GEI dental come from outside suppliers (see Chapter 5, section 5.5.2. 
Potential suppliers) and the SS is responsible for the manufacturing of the GEI dental device. The 
manufacturing consists in assembling and testing. SS team is responsible for properly assembling all 
components in order to obtain a high quality product. Afterwards, the product is tested in our 
installations, because if any kind of problem occurs it can be repaired before it is delivered to end-
users. 
The product, after being manufactured, will be commercialized by two ways: either directly to the 
dental laboratories or through distribution companies. The direct sales to the dental laboratories will be 
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performed by SS team directly to the dental laboratories. On the other hand, the GEI dental can also 
be sold by companies specialized on the sales of dental equipment which usually supply the dental 
laboratories. As mentioned in Chapter 5, this type of companies has a high level of involvement and 
knowledge about dental industry and as consequence it is a great option to commercialize and spread 
the product. In addition, the distribution company will be responsible by the maintenance of GEI dental 
after being sold. Therefore, the SS presents a positioning in the dental industry value chain as a dental 
laboratory supply (Figure 7.1). 
 
 
 
 
 
 
 
 
 
Figure 7.1.  GEI dental value chain.  
  
The steps to increase the value capture to GEI dental are presented next: 
 
1. Since the product is very recent, it will be essential to develop, improve and test it. 
2. GEI dental will be mainly presented to the dental market as an innovative, useful and 
necessary product which will improve dental prostheses. 
3. Besides the product’s improvement, dental prostheses stand forward by the use of 
supercritical fluids which become a friendly environmentally product. GEI dental appears as an 
emergent technology targeted to sustainable development.  
4. Participation in competitions of entrepreneurship and innovative technologies, in order to 
obtain financial means to support the company in a first stage. 
5. Directing sales to the dental laboratories or selling through dental suppliers according to what 
becomes more advantageous. In the beginning of the commercialization of the product in 
Portugal, directing sales to the dental laboratories seems to be the better option. 
6. Personalized and high quality service, including availability of monitoring and clarifying the 
customer when necessary. In addition, the responsibility to saving the equipment maintenance 
which will be an additional paid service. 
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7. The participation in dental fairs in which the product will be presented to potential customers.  
8. Create a solid network in the dental industry.  
9. The possibility of partnership or associations with dental companies interested in new 
products, which makes the product more competitive and allows a bigger acceptation in the 
dental industry. 
10. In addition, the acrylic is used in many other areas besides dentistry. As a consequence, the 
commercialization of the equipment may be extended to other areas. 
11. The company will always be involved in research with the purpose of enhancing and 
developing new applications to GEI dental, increasing its market. 
 
7.3. Revenue model  
 
Generating revenue allows companies sustaining themselves and that is an important issue in any 
business. 
 
The mainly source of revenues of SS comes from the sales of the device. Besides the profits related 
to the sales of the GEI dental device, the profits will come from the maintenance of the device which 
includes periodic cleans and checkups. Therefore, the company will be generating its revenue sales 
both by selling the GEI device and by maintenance services.  
 
The sale will be directly to customers with a practical demonstration or through an intermediary as 
mentioned above. The device and the other services will have a fixed cost which will be presented to 
the customer in the beginning of the contract. 
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8. Marketing Plan 
8.1. Vision, Mission and Objectives 
 
Vision  
Sustainable Solutions wants to be recognized as a high quality company which contributes to 
technological progress.  
Mission 
Sustainable Solutions aim to make available safe and environment friendly technologies to improve 
dental care.  
Objectives 
The company’s objectives are the following: 
1. Attracting potential customers: the main goal of the company is to enter into the dental indus-
try, so the acquisition of first clients is primordial. 
 
2.  Acceptance of the dental sector as an important product to lead the dental prosthesis to an-
other level. 
 
3.  Partnerships with components suppliers’ as well as influent dental companies: the establish-
ing of partnerships with distribution companies and suppliers guarantees an efficient delivery 
service. On the other hand, the partnership with dental companies can be important to imple-
ment GEI dental in the market. 
 
4. Company proposes effective solutions to create innovative and high performance oral care 
products using a sustainable technology. 
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8.2.  SWOT Analysis 
 
 
Strength 
 Innovative technology 
 Product environmentally friendly  
 Increase of dental prostheses value 
making the  process more successful 
and less painful  
 Improvement of PMMA, reduction of the 
cytotoxicity. 
 Slowing infections and rejections of 
dental prostheses wearers 
 Introduction of supercritical technology 
on health care market   
 
 
 Weakness 
 Duration of extraction and impregnation 
processes 
 Alternative materials to the acrylic have 
been used in dentistry  
 High costs of the components that consti-
tutes the product 
 The high product price 
 Time needed to optimize the product 
 High development cost  
 New company with an innovative product 
 
Opportunities 
  Aging people  
  Increase of dental prosthesis wearers 
 Huge market potential 
 Patients’ concerns for quality treatment 
 Increase patients’ demand for more  
 Growth of dental industry - intensive  
       needs for more dental equipment,     
material and technologies 
 Partnerships with influent companies 
 Need/demand for new technologies 
 Demand for environmental technologies 
 Concern with future generations (devel-
opment sustainable)  
 
Threats  
 Development of competing materials  
 Patent expired  
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8.3. Marketing Mix 
8.3.1. Product  
In the development of a product, it is necessary to define the benefits that the product can be offer to 
the client [63]. Following next, the attributes of the product will be exposed. 
Features 
GEI dental is a device with two distinct functions: 
 
o Extraction of residual monomers MMA which has been related as responsible for 
allergies (Chapter 3 Market Pain). 
 
o  Impregnation of acrylic (material used in dental prostheses) with an antimicrobial, 
anti-inflammatory, fluor or even a substance against malodor 
 
The main feature of the device is the use of SCF, particularly the scCO2. The equipment, which was 
intended to marketing, is evolving to sustainable development. The market trends are going in the 
direction of this new approach, which replaces old and pollute organic solvents. Therefore, the 
product, besides improving the properties on most of the used materials in dentistry, and also in others 
areas, helps the future, which is essential to preserving the world for future generations. 
 
Quality 
Quality is essential in our product because the equipment will be used with the purpose of improving a 
medical device.  The trust in the product is crucial to attract the customer’s confidence, as to ensure 
that the equipment respects the strict rules associated to medical devices and does not to change any 
important property of dental prostheses. The quality is ensured by competent regulatory entities and 
the product has all required certificates as described in Chapter 6 in section Regulatory Concerns.  
 
Design 
The product’s design takes into account two main aspects presented next: 
 
 Simplicity – The equipment will be all automatized so that any person is capable of using it, 
because it is essential take into account that the device will be used by dental technicians 
without any knowledge about supercritical fluids. 
 
 Size – Dental laboratories do not usually have large areas, so it is important that the device 
does not occupy a large space.   
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 Appearance- The outside part of equipment is another feature to be considered because the 
appearance also conveys a message. The product should look sophisticated, modern and 
simple. 
 
Logotype 
 
 
 
 
 
 
 
Figure 8.1. SS logotype. 
 
The colors, image and letters’ type have been taken into account in the logotype. The use of green is 
on purpose, in order to transmit the concern and commitment to developing sustainability. Blue is 
associated to health care sector. The global image is clean and sophisticated as the company itself. 
Slogan: Dental care moves to a sustainable future free from diseases. 
Packaging 
The device should be well packaged as to guarantee quality and avoid damaging during 
transportation, in order to arrive to the customer in perfect conditions. In addition to the importance of 
a well packaging, the logo will be presented in the package. 
Guarantee  
The company ensures solving any problem in a two year period after acquiring the product.   The 
period of guarantee was chosen based in the guarantee periods considered by dental companies. 
 
 
 
ustainable 
olutions 
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8.3.2.  Place 
 
In this section the best and most advantageous way of delivering the product to the customer is 
discussed. 
Firstly, it is important to define how transportation is being done to the customer to commercialize GEI 
dental. Due to high logistic costs related to transportation, usually only companies with a large 
dimension, with both great volume sales and market penetration, have their own transportation 
department.  
The business will initially be only in Portugal, including the company’s office. There are already several 
Portuguese companies responsible for dental products’ distribution. However, Portugal is a small 
country, as well as the dimension of the market, and so this is one of the reasons why it is our market 
test. Therefore, in the early stage of the company, low amounts of orders are expected and, as a 
consequence, it is predictable that the process of transportation will be simple. Although it is 
considered that the companies in an early stage should be delegate the distribution to specialized 
firms be a better option, the direct distribution may probably be a better option during the first stage of 
commercialization in Portugal, and the SS team could be responsible for publicizing and 
commercializing the product. 
After the product is implemented in the Portuguese dental market, it is expected to be expanded to the 
European dental market. The European market requires a quite complex network distribution because 
of its large scale. As mentioned in Chapter 5, there are already well-defined networks of dental 
products distributing across Europe. Using the referred distribution companies seems the best option 
to GEI dental.  An important feature is looking for dental distribution and making partnerships with 
them to guarantee a delivery service of quality to our customers. These companies present 
professionals with a good knowledge of this sector and usually have a high range of clients, which 
assures facilitating the access to them. In conclusion, the option of distribution through an intermediary 
could be a good choice in a first stage of the product’s presentation in international dental market, in 
order to provide an extensive and easier promotion of the product. There are several trade channels 
responsible for the dental equipment distribution, however, it is important to choose a company 
interested in publicizing and marketing our product. One of the options is creating an exclusively 
contract with a company.  
8.3.3. Promotion 
The communication of company value propositions to customer is an essential point to consider on 
establishing and maintaining any kind of relationship with customers [55]. In launching a new product, 
its disclosure is extremely important. Therefore, the outlining of the product’s promotion is one of the 
most important actions which deserve the maximum of attention and effort. A successful promotional 
campaign is crucial to the product’s introduction in the market. 
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Personal selling 
In the healthcare sector, where trust is essential, direct contact is the strategy that has been used the 
most. GEI dental will be adopted as a personal selling tool in order to establish a relationship with 
customers based on trust and proximity. 
In the case of GEI dental, this tool is highly important because it allows this innovative product to 
expose its features and benefits. In addition, this tool also allows explaining how the device operates 
by a practical demonstration and receive the customers’ feedback by perceiving their reluctance and 
needs. 
The company will have a department specialized in this kind of sales in order to guarantee that the 
promotional actions convey the right message to the potential customer and with the purpose of 
improving through time. 
Public relations 
The presentation of the product in dental industry is important to launch both the product and the 
company itself. There is a high range of events in this area, such as conferences and dental fairs. The 
company’s presence in that type of events is essential to begin to build a solid network. 
The company will select some of the most important events based on geography and presence of 
potential customer targets, in which the company will promote their message and product.   
 Advertising and sales promotion 
Besides divulgating the product in dental laboratories, it is important to publicize it among dental 
prostheses wearers and dentists. The product’s publicity oriented to dental prostheses wearers is a 
tool to become popular among final customers. Thereby, the patients will start asking to their dentistry 
about this product and, as consequence, the dentist will require to laboratories this innovation in the 
dental prostheses ordered. 
Nowadays there is already a high range of platforms through which the publicity of the product is easy 
and does not involve high costs. In addition, these platforms allow promoting the product to a large 
number of people, including not only dental laboratories but also the potential users of dental 
prostheses manipulated by GEI dental.  This is extremely important to access and approve the 
product.  
Examples of platforms are presented next. 
The website is the simplest and cheapest way to present our company and products to the potential 
customers. Nowadays all companies have a website where they expose their values and what they 
intend to offer to their customer, therefore it is an important tool to promote not only the products but 
also the company’s message. The website should be conveying a proper image of the company and 
products. In our case, the website should be presenting a green message, in other words, it must be 
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showing to website viewers that GEI dental is meeting the sustainable development and concern 
needs about future generations. In addition, another purpose of the website is to show the needs of 
dental prostheses wearers and how this high quality technology can solve them. 
The email is an important and easy tool to establish the first contact with potential customers. This 
platform allows promoting GEI dental more directly to dental companies. 
In addition, this tool is also useful to promote the existence of this product to dentists because the 
dentists could start to require this technology on the dental prostheses ordered to laboratories.  
Social networks are another useful platform especially to present the product to the general public. 
By presenting the product on social networks, it may allow the public to question why their dental 
prosthesis do not already have this innovation and eventually ask their dentistry, in the next 
appointment, why that is so. Therefore, this platform basically allows promotion to a high and global 
range. This tool is also relevant to another important purpose of the company-the concern for 
sustainable development. Social networks play an important role in public opinion turning out to be a 
great means of demonstrating the importance of these companies which commercialize green 
products replacing old and damaging technologies, such as organic solvents. 
8.3.4. Price  
The definition of the price of the product is always a complex process, and so several aspects need to 
be considered. 
Product costs 
Firstly, it is important to take into account how much will be spent to manufacture the device, including 
all the materials and workforce.  
The company should determine its fixed costs and variable costs associated to the manufacturing of 
the product. The required materials to compose the device have high costs, as well as the workforce, 
which should be specialized technicians, also requiring high costs. Therefore the price of the 
equipment will have high costs of manufacturing, and the product will become uneconomic.  
Price of similar equipment 
The use of supercritical fluids in dental industry is a novelty, so in fact there is not any similar 
equipment. However, both the prices of the other equipment presented in dental laboratories and the 
prices of the devices associated to supercritical technology with other purposes were considered. The 
price of supercritical technology is much higher than the prices of the equipments used in dental 
laboratories. 
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Product price 
The expenses associated to the components’ costs will determine the final price of the GEI dental. The 
price that the GEI dental will have is 45 000€. The price is very high comparing to the common dental 
equipment because the high cost of the components that are required to assemble GEI dental lead to 
the mention value.  
Value created to the client 
Another important feature that is important to define is payback, in other words, the time that a client 
delay to recover the money invested in the GEI dental device. The parameter considered was the 
number of dental prostheses sales during a month by dental prosthesis. Therefore, by an estimated 
number of dental prostheses sales and by adding an extra value in the price of dental prostheses, a 
payback is possible to predict. The knowledge of this value by the customer is important because it is 
a parameter that will be present in the purchase decision.  
Then, after consulting some dental professional of target customer, it is possible to define a credible 
add value created to the client by GEI dental. The add value that the dental laboratories could perform 
to each dental prosthesis manufactured is about 50 €.  Considering that a dental laboratory does not 
make less than 30 dental prostheses per month, the payback will be in less than 3 years. In the case 
of large laboratories, for example Maló Clinics which was a dental laboratory address, and according 
to the dental professionals addressed, they produce 600 or more dental prostheses per month. 
Looking at both scenarios, the large and the small dental laboratories, a 2 year payback was 
considered, which is very positive. 
 Customer perception of pricing 
In order to obtain a considerable profit of the product, it will be presented to the dental market as a 
product of high quality and that reflects on the price.  The product which is intended to be 
commercialized is innovative, made by green process and technologically complex. Therefore, the 
features of the product above mentioned justify the high price. 
Although the initial perception of future customers about the price could not be the best, since they 
could be considering it too high, the payback is about 2 years, which is a reasonable time to make the 
investment worth.  
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9. Product Development and operations plan 
 
9.1. Prototype to finished product 
 
GEI dental still needs to be developed in certain aspects to convert the prototype to a finished product 
available for marketing. The idea of this product has recently emerged and as a consequence there 
are still several parameters to be developed. Probably a year will be at least necessary to develop and 
test the product before reaching the market. The main points to take into account are discussed and 
listed below. 
 
The only tests made were to inquire and verify whether this technology could be applied to dental 
prostheses. So, the product needs to be developed and tested. Firstly, a primordial issue is defining 
the optimal conditions of operation, which will require a significant time and commitment. The main 
objective is to define the operation conditions (temperature and pressure) in the shortest operation 
time possible, obtaining an efficiency process. In addition, it is necessary to test the impregnation of 
different active principles. The active principles usually used in dental care will be tested in order to 
offer a high range of viable and efficient options to the customer. In conclusion, in a first stage, to con-
vert the prototype into a finished product, it is essential to define a better process of extraction and 
impregnation, in order to take the maximum advantage of technology and guarantee a high quality to 
the product.  
 
After the product being optimized in order to guarantee the maximum efficiency of processes, the 
equipment being completely automatized is other aspect to take into account in the prototype conver-
sion into a finished product. So, the device should have an electrical component. Afterwards, due to 
the dental laboratories usually not presenting large dimensions, the device should have a relatively 
small size.  Therefore, converting the initial prototype in a product with these parameters is essential in 
order to turn this technology saleable and easy to use.  
 
9.2. Equipment 
 
The equipment required will be simple, only the common office equipment and the equipment neces-
sary to manufacturing the product. Concerning the common office equipment, tables, computers and 
chairs will be necessary. Communication tools, such as cell phones and portable computers are also 
required equipment by the team.   
 
In manufacturing the device, the necessary equipment will be protection eye glasses and a box tool, 
which brings all the necessary material to assemble the GEI dental. 
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As mentioned above the main components that constitute the GEI dental are: 
 
5. Liquid pump 
6. Valves 
7. High pressure vessel 
8. Back Pressure Regulator (BPR) 
9. Compressor  
10. Temperature and Pressure gauges 
11. Filters 
 
9.3. Geographical Location 
 
Besides the SS being an assembly company, the better location for the company is a warehouse in an 
industrial area. The space does not need to be very large, which is an advantage considering cost.  
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10. Team  
 
The SS team is a crucial issue because the success of the company depends also on a good and 
adequate team that will maximize the chances of success. The company requires a high specialized 
teamwork in different areas with high motivation in order to create a successful company.   
 
The SS organization there will be two stages. Initially, having a workforce with knowledge about su-
percritical fluids is primordial, in order to develop, improve and test the product. Another essential re-
quirement is a specialized team in electronics to help the conversion of the prototype into a finish 
product. A team with the referred skills of about three people is required initially in the first year, when 
the product is still being developed.  
 
On a second stage, when the product starts to be commercialized, the team can be increased and 
divided in specific departments following described.  
 
Research and Production 
 
Two elements of the first team referred above are maintained in the production and research depart-
ment. The technicians with electronic and supercritical knowledge are responsible for manufacturing 
the device. They will be charged for the development and research of the product. In addition, to the 
technical skills, it is important to show passion about what they are doing and dedication because they 
need focus in the project. 
 
Marketing and Sales  
 
The marketing and sales department will be given to one person with the proper profile. This person 
will be responsible for the divulgation, promotion, product sales of the company and its products. 
Therefore, having people with both communication skills and a deep knowledge of the product, includ-
ing the technology and dental area, is important.   
 
Finances 
 
The company’s finances should be given to a person with proper skills and knowledge about finance 
management. An accountant is essential because it is important the company present a stable and 
positive financial situation.  The referred person could be a freelancer accountant who treats the com-
pany’s accounts monthly. 
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Project Management 
 
Coordination and organization are vital to the good functioning of any company. This department is 
responsible for taking important and crucial decisions, concerning both human resources management 
and production issues. The organization must have someone who keeps people focused on a daily 
basis. This person should be able to lead the group and ensure that all aspects of the project are cov-
ered and this function will be played by the CEO.  
 
According to the departments division mentioned below a SS organogram is presented. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 10.1. SS Organogram. 
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11. Implementation  
11.1. Financial Plan 
The financial plan was made to five years of SS activity and it starts in 2013. The product’s develop-
ment is performed during the first two years and the commercialization will start in 2014. The studies 
with the purpose of developing the product will continue to take place in IBET. The projections made 
during the implementation of this financial plan are only estimated values and not precise values. 
11.1.1. Revenues 
Sales’ projection will be presented next in Table 11.1. The estimated values are supported by the 
conversations with the dental professionals addressed, on the development of dental industry over the 
last twelve years and the next eight years and on the market size (Chapter 5). These values are 
uncertain due to being very difficult to predict who will indeed buy GEI dental.  
The revenues will come from the sales of the device and by the maintenance of the device (only the 
devices sold in Portugal) which includes periodic cleans and checkups. The selling price stipulated to 
each GEI dental will be 45 000 € and the price of each maintenance services will be 100€. The GEI 
dental should need maintenance at least two times a year. 
 
Table 11.1 Sales projection for the first five years of SS activity. 
 2013 2014 2015 2016 2017 
Sales in Portugal - 6 15 30 30 
Spain - - 4 15 30 
Other European 
countries 
- - - 30 60 
Number of sales 0 6 19 75 120 
 
Table 11.2. Revenues projection for the first five years of SS activity 
 2013 2014 2015 2016 2017 
GEI dental sales Revenues (€)  270 000  855 000  3 375 000 5 400 000 
Maintenance sales Revenues (€)  1 200 3 000 6 000 6 000 
 
Sales Projection 
In 2013 the SS will advance only on the development of the product, consequently it will not be sold 
any device this year. In this first year, it is expected to develop the product until obtaining the best 
possible extraction process of MMA (in terms of efficiency and time). On the other hand, in terms of 
the impregnation process, it is expected unless one active principle to be impregnated in dental 
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prostheses with the maximum efficiency possible and with the proper parameters required by the 
dentists (short time of process, amount of active principle to impregnate well study, including drugs 
release profile well known). 
In 2014 the development of the product continues and more systems of impregnation will be 
developed in order to obtain a more versatile product to meet orthodontia needs. After obtaining the 
final product, the next step is to patent the final product and the accreditation and validation by 
regulatory authorities in order to have a high quality product to be commercialized. In this year, it was 
assumed to sell about 6 devices to the biggest and more developed dental laboratories in Portugal, 
which are the Portuguese laboratories interested and receptive to new technologies 
In 2015, it is expected to have the final product more complete with a high range of impregnation 
systems with different active principles well studied and explored. The product should be prepared to 
be presented to international market, so the international patent of the product will be required. The 
first international dental market to which GEI dental will be presented is the Spanish due to being the 
closest country geographically.  
In 2016 a jump on the product sales’ is assumed, because the product is expected to present a sound 
position in the European dental market. In the next two years, the continuing growth of the sales is 
predicted because it is believed that, due to GEI dental being a high quality product and meeting 
orthodontia needs, after be divulgated in European market, it will be required by most of the dental 
laboratories.  The main factor which could bring caution to the projection sales or that could lead to the 
failure of the projection sales is the high price of the device, which can induce the laboratories not to 
acquire GEI dental. 
 
 
 
 
 
 
 
Figure 11.1. Activities timeline for the five years of the SS company. 
 
 
 
 
 
 
             2013 
 
 
Product development 
2014 
       Obtaining Final Product 
 
National Patent 
 
    Obtaining CE marking 
 
Commercialization 
 in Portugal 
2015 
 
International Patent 
 
Commercialization 
 in Spain 
 
 
2016 
 
 
Commercialization 
 in European Market 
 
 
71 
 
11.1.2. Expenses  
Several costs must be taken into account, such as marketing costs, human resources costs, research 
costs, among others. 
Table 11.3. Expenses related to the first five years of SS company activity. 
Expenses (€) 2013 2014 2015 2016 2017 
Research and product 
development 
5 000 5 000 _ _ _ 
Equipment 60 000 _ _ _ _ 
Certifications _ 30 000 _ _ _ 
Industrial Property _ 2 000 6 000 _ _ 
Office Rent 2 400 2 400 2 400 2 400 2 400 
Total 67 400 39 400 8 400 2 400 2 400 
 
Research and Product development  
The product will be developed during the first two years. Although the product initially will be 
developed in installations of IBET, there will be costs associated with the necessary experiments to 
develop the product. Current material of laboratory will be necessary, samples of active principles and 
CO2 cylinders.  In addition, it will be necessary buy protection equipment, such as eye glasses 
protection and to buy material necessary to assembly the GEI dental, such as a tool box. 
Equipment 
The expenses associated to the equipment include the triple of the costs associated to the acquisition 
of a similar device of the product expected to commercialize, in order to perform the experimental and 
prototype tests, the cost of each equipment is around 20 000€.   
Certifications 
The estimated value to certification expenses is based on the official website of CE marking. 
Industrial Property 
The industrial property strategy will comprise two steps: in 2014 the national patent of the final product 
will be required and in the next year the international patent. 
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Office rent   
The value considering to office rent is real and includes all the office equipment. 
Table 11.4. Marketing expenses in the next five years of SS activity. 
Marketing 
expenses (€) 
2013 2014 2015 2016 2017 
Website design 500 - - - - 
Trade shows - 9 000 9 000 9 000 9 000 
Other costs 500 2 000 2 000 2 000 2 000 
Total Cost 1 000 11 000 11 000 11 000 11 000 
 
Website design 
The Website is an important tool to divulge the company and the product (Chapter 8). There are 
several companies specialized in the creation of a website according to the image and message that 
the company intends to show.  
Trade shows 
Trade shows are important events to publicize the GEI dental and it is expected that SS will annually 
go to at least three trade shows. The value includes the cost with the travels, accommodation and 
other fairs’ expenses.  
Other costs 
Other costs refer to expenses with transportation and promotional actions associated to the publicized 
product, which include visit cards, leaflets, screens and others. The value is only an over supposition 
and does not have any real support. 
Table 11.5. Human resource costs. 
Annual salaries* (€) 2013 2014 2015 2016 2017 
CEO 8 400 14 000 21 000 21 000 21 000 
2 Specialized Technicians 14 000 22 400  28 000 28 000 28 000 
Accountant 2 400 2 400 2 400 2 400 2 400 
Marketing Manager - 12 600 14 000 14 000 14 000 
Total costs 24 800 51 400 65 400 21 000 37 400 
*14 months are taken into account 
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Table 11.5 presents the salaries of SS’s team for the first five years of activity. The salaries were based 
on the current salaries practiced in Portugal, including the value attributed to pay annually to the 
freelancer accountant who deals with the company’s accounts annually. 
Table 11.6. Variable costs during for the first five years of SS’s existence. 
Variable 
expenses (€) 
2013 2014 2015 2016 2017 
Components _ 120 000 380 000 1 500 000 2 400 000 
Royalties _ 2 712 8 580 33 810  54 060 
Transportation _ 3 600 3 600 3 600 3 600 
Distribution _ _ 63 000 708 750 1 417 500 
Total _ 6 300 75 150 746 100 1 475 100 
 
Components 
The components are the necessary components to assemble the GEI. 
The variable costs are the cost that will depend on the unit of the devices sold. The costs entailed by 
SS with the components that constitute the product depend on the unit sales, the materials will be 
ordered according to the devices ordered by dental laboratories. The price of each material necessary 
to the GEI dental assemblage was based on real values performed by the suppliers’ companies. The 
materials will have a cost of 20 000 € per unit sold, this value is the soma of the price of the each 
component that constitutes the GEI dental device. The price of each component is based on real 
values practiced by supply companies. 
Royalties 
Since all the research and one of the patent owners is IBET, it has the right to royalties on the devices’ 
commercialization. Royalties in the field usually range from 1% to 5% for each unit sold. This value will 
be negotiated before starting the commercialization, but in the financial plan it was considered 1% 
because usually the start-ups get good accords.  
Transportation 
Transportation costs are related to expenses to move across Portuguese territory, which includes the 
transportation of the product to the customer. 
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Distribution 
Distribution companies are used to international commercialization, and to the financial plan a margin 
of 35% of the product sales’ was considered to the respective companies, in other words, 35% of the 
revenues by the sales of the product in the international market will be to the distribution company. 
The margin considered was based on the commonly margin practiced by the distribution companies. 
In Appendix 7 is presented financial plan in detail. Looking to Free Cash Flow is possible to verify that 
an investment of 200 000 € will be necessary to founded SS company. The Net Present Value 
(NPV)(15%) to the first five years of activity is 35 501 € and the payback period is 3 years. Finally, the 
Net Profit after tax of the last year is 1 059 926€.    
11.2. Critical risks 
The high cost of the components that constitute GEI dental are reflected on the price of product to the 
customer. Probably it is the highest risk to overcome. The components which compose the device 
have a high cost and the technicians required must be specialized.  Therefore, the product will be 
presented to the dental market with a high price which could be a barrier in the acceptance by dental 
laboratories.  
 
Furthermore, a concern about the product is the possibility of the optimal conditions achieved not 
being the best to the dental professionals. In order to obtain the final product, there are several 
conditions and points which will have to be tested, developed and enhanced. So, there is the 
possibility that the product has not the exactly characteristics required by dental professionals. Another 
risk related to the aspects referred above is the possibility that important active principals may not be 
associated to this technology. This risk is associated to the product being a new idea and the active 
principles appointed by the orthodontists not being yet tested. 
 
There is the possibility of not obtaining enough financial support in a first stage of research and the 
product’s development, because interested investors could appear only when the final product was 
already. Probably, in a first stage of development, the financial support will only come through funds 
and prizes, which has an associated risk because there is the possibility of not obtaining any funds or 
these funds not being enough. 
 
The projections sales fail can be another risk. Despite the initial sales being supported in the 
interviews by potential customers, there is not a guarantee that the referred customers will buy the 
product and for a long period the sales projections will only be supported based on the market size 
and in the growth of the dental industry. Therefore, the value given to sales projection is very uncertain 
and there is a high error margin. 
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12. Conclusion 
There are several possible applications to the GEI technology. The extraction of MMA from the acrylic 
used in dental prosthesis and the dental prostheses impregnation with active principles was the 
application considered most interesting to taking GEI technology from the laboratory to the market . 
 
Due to the GEI dental being a new idea, it was necessary to test the effectiveness of the technology 
applied to dental prostheses. The extraction and impregnation concept applied to dental prostheses 
was validated through the results of the experimental tests performed. According to experimental 
tests, GEI dental is able to extract about 68.7% of MMA present in dental prostheses through a 
process, which lasts about 50 minutes. In addition, GEI dental allows the impregnation of ibuprofen 
with a %impregnation of about 7% in a process about 60 minutes long, in order to increase the 
%impregnation to 8% the duration of the process must also increase. The experimental tests results 
were very promising which strengthens and increases the potential of this product. Other additional 
experimental test should be done to develop and improve this new idea in order to obtain a final 
product with a high quality and useful characteristics.  
 
The next steps are enhancing the extraction process and develop new impregnation systems with the 
required active principles by the orthodontists The impregnations systems should be developed taking 
into account the amount of active principle recommended by the orthodontists, and the drug release 
profile well known and approved by the orthodontists. Therefore, the impregnation systems should 
have developed together with the orthodontists. 
 
The potential customers of this product are the dental laboratories, and the final users are the dental 
prosthesis wearers. The target market of this technology are the large European dental laboratories 
which are interested in innovation and with a solid financial situation. Portugal was the country chosen 
as the market test for this product. Malo Clinics is one of the target customers, and some 
professionals of the referred company were addressed. The feedback was very positive, which 
supports the importance and the need of the GEI dental. During the development of this master thesis, 
it was possible to verify how important a product with these characteristics could be in dental market.  
 
The GEI dental should be in costumers’ mind as an innovative, hi-tech, sustainable, useful product, in 
which meets a need of the orthodontia.  
 
Analyzing the GEI dental characteristics related to its competitors, it is possible to mention the 
following advantages – decrease of the risk of allergies due to the extraction of residual monomer, 
reducing the acrylic resins cytotoxicity, giving dental prostheses new functions, such as allowing dental 
prostheses users to have a fresh breath and take diary medicine. Furthermore, GEI dental could allow 
the prevention and treatment of infections.  
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Due to the patent of the technology having expired, it will be important to submit a new patent. 
However, the process of patenting is complex because it is necessary to fulfill all the criteria required 
and achieving some criteria could be difficult. On the other hand, the final product is absolutely new, 
there is not any device with similar functions in the dental market, and so patenting the final product 
could be an option to obtain intellectual protection. Concerning regulation issues, no problems are 
expected, since it is a safe technology without any risk to people’s health. So, GEI dental should fulfill 
all the required criteria by CE marking.  
 
The business strategy will be based on the creation of a start-up, SS, which, in an early stage, will be 
focusing on the product’s development until a final product will be obtained with the desired 
characteristics. Afterwards, the company will be responsible for assembling, testing and 
commercializing the GEI dental.  
 
The marketing plan aim is to present the GEI dental as a hi-tech, sustainable and useful product in 
order to have great acceptance by the orthodontia sector and make important partnerships.  
 
The product is in an initial stage and so several points should be taken into account to convert the 
prototype into a finished product ready to be commercialized. After obtaining efficient process of 
extraction and impregnation, size, design and simplicity of the manipulation of the device are other 
aspects to take into account in the prototype conversion into a finished product. The final product must 
have a small size, with a modern and sophisticated appearance and completely automatized.  
 
The financial plan was made to first five years of SS activity appoint to an initial investment of 200 
000€ with a payback of 3 years. The NPV (15%) to the first 5 years of activity is 35 501 € and the Net 
Profit after tax of the last year is 1 059 926€.  
 
The main critical point is the high price of the GEI dental, which can lead to difficulties in selling the 
product to the dental laboratories. The product price is much higher comparing with to the prices of the 
equipment used in dental laboratories. Despite this, the time that a client delay to recover the money 
invested in the GEI dental device, the client payback, is less than 3 years, which is a reasonable time 
to make the investment worth. So, although the initial perception of future customers about the price 
could not be the best, since they could be considering it expensive, the payback can balance the initial 
perception of the high price.  
 
Analyzing the entire Technology – Market Transfer Plan, it is possible to verify that, by attributing an 
innovative application and with a market need, it is possible to bring a technology, until now in the 
laboratory, to the market and with a potential to be commercialized. The application of this supercritical 
technology to dental prostheses was a successful choice, because according to the gathered 
opinions, the dental industry is receptive to this product and there is a considerable market size to 
commercialize the GEI dental.  
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Appendix 1: Performance Map of Medical Pacifier 
 
Table 1.1. Comparative analysis of main competitors of pacifier impregnated with a medicine. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Portugal USA UK USA USA USA USA USA 
 GEI Safety 1st 
pacifier 
Mothercare TYKES Munchkina Wyoming Dr. 
Brown’s 
Kidz-Med® 
   
 
 
  
 
 
 
  
Price (€)  
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Easy dispense 
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Appendix 2: Summary of the dental professionals’ interviews 
 
In order to have a feedback about what dental professionals think about this product, several dental 
professionals were addressed. The summary with the main questions made during the direct contact 
with dental professional is present in table 2.1. 
Table 2.1. Summary of the interviews made during the direct contact with dental professional. 
 
 
Is it 
interesting 
to associate 
this 
technology 
to dental 
prostheses? 
Dental 
prostheses 
disadvantages 
and 
pathologies 
What 
substance or 
medicine are  
interesting to 
be released ? 
Observations 
about the 
product (*) 
 
João 
Carlos 
Roque 
Representing 
Nobel Biocare 
and 
Professor of 
Faculdade de 
Medicina 
Dentária de 
Lisboa (FMDUL) 
 
Yes 
_ 
-Promote the 
Healing 
-Anti- fungi 
-Daily 
medicines 
“An interesting 
idea” 
“It is interesting 
and new to the 
dental industry” 
Luis 
Loureiro 
Orthodontist Yes 
Negative 
charge of the 
removable 
prostheses 
-Fluor 
-Antibiotics 
-Amoxicillin 
-Anti-fungi 
“Interesting 
application” 
Sandra 
Ribeiro 
Professor of 
FMDUL 
and 
Oral Hygienist 
 
Yes 
Bacterial and 
fungi 
colonization; 
Candidiases, 
Allergies to the 
acrylic resins 
-Anti-fungi 
-hygienic 
products 
-Chlorhexidine 
“It will be 
useful” 
Profissionals addressed 
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Is it 
interesting 
to associate 
this 
technology 
to dental 
prostheses? 
Dental 
prostheses 
disadvantages 
and 
pathologies 
What 
substance or 
medicine are  
interesting to 
be released ? 
Observations 
about the 
product (*) 
 
Henrique 
Luis 
Professor of 
FMDUL          
and Oral 
Hygienist 
 
Yes 
_ 
-Anti-fungi 
-Hygienic 
products 
_ 
Luis 
Jardim 
Dentist Yes _ 
-Anti-
inflammatory 
 
_ 
 
 
Jaime 
Portugal 
Dentist, 
Professor of 
FMDUL           
and          
President of the 
Sociedade 
Portuguesa de 
Estomatologia 
Dentária 
 
Yes 
 
MMA release 
inside the 
mouth (allergies 
focus) 
-Anti-
inflammatory 
-Anti-fungi 
-Chlorhexidine 
 
“Important to 
know the period 
of time that the 
active principle 
is released” 
 “Interesting 
product” 
 
António 
Silva 
Maló Clinics 
Ceramics Dental 
Laboratory 
Coordinator 
 
Yes 
 
 
-Chlorhexidine 
 
-Hyaluronic 
acid 
“There are 
several patients 
who react 
negatively to 
the acrylic, this 
technology 
could be a 
solution”            
          
“Interesting 
product”                    
                                 
Profissionals addressed 
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Is it 
interesting 
to associate 
this 
technology 
to dental 
prostheses? 
Dental 
prostheses 
disadvantages 
and 
pathologies 
What 
substance or 
medicine are  
interesting to 
be released ? 
Observations 
about the 
product (*) 
 
Miguel 
Nobre 
Maló Clinic 
 
Yes 
_ 
 
-Chlorhexidine 
 
-Hyaluronic 
acid 
“I am very 
interested in a 
product with 
these 
characteristics” 
“you have an 
interesting 
project in 
hands” 
 
Bruno 
Seabra 
Orthodontist 
Maló Clinic 
 
Yes 
 
_ 
 
- 
Chlorhexidine 
 
-Hyaluronic 
acid 
“It is an 
interesting 
product” 
“The product’s 
features are 
interesting” 
“The MMA 
extraction is a 
great idea, with 
a huge interest” 
Filipa Brás 
Dental 
Prosthesis 
technician 
and 
CEO of the 
Highland 
Factory 
Yes - - 
“Product with 
useful 
characteristics” 
“since it is a 
new company, 
It may be an 
add value to the 
company 
because it 
could help to 
demark from 
my competitors” 
*The product was presented to dental professionals before the experimental tests, so the product 
presented to the dental professionals was the product which is intended to obtain. 
Profissionals addressed 
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Appendix 3: Online questionnaire performed to the Portuguese dentists  
 
In order to inquire the opinion and acceptation of the dental professionals, particularly the dentists, an 
online questionnaire about dental prostheses was performed to the dentists. The sample was of 20 
Portuguese orthodontists.  
 
1. Which type of dental prosthesis is more used by your patients?     
 
Figure 3.1. Proportion of the type of dental prosthesis more used (question 1). 
 
2. Which age is more common to put/use dental prosthesis? 
 
Figure 3.2. Age group which more often uses dental prostheses (question 2). 
 
 
36% 
64% 
fixed
removable
73% 
27% 
36-65
>65
90 
 
3. The percentage of patients with problems due to dental prosthesis use 
 
Figure 3.3. Patients with problems due to dental prostheses use (question 3). 
 
4. The relevance to impregnate dental prostheses with an active principle which would be gradually 
released inside the mouth (1-no relevant, 5- very relevant): 
 
Figure 3.4. Relevance of the dental prostheses impregnation (Question 4). 
 
 
 
 
 
82% 
18% 
0% 
1 -3 in 10 patients
4-5 in  10 patients
 Up to 6 in 10 patients
9% 
9% 
55% 
18% 
9% 
1
2
3
4
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5. Relevance of the antibiotic impregnation (1-no relevant, 5- very relevant). 
 
Figure 3.5. Relevance of the dental prostheses impregnation with an antibiotic (Question 5). 
 
6. Relevance of the anti-inflammatory impregnation (1-no relevant, 5- very relevant). 
 
 
 
Figure 3.6. Relevance of the dental prostheses impregnation with an anti-inflammatory (Question 6). 
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7. Relevance of the healing impregnation (1-no relevant, 5- very relevant). 
 
 
Figure 3.7. Relevance of the dental prostheses impregnation with a healing (Question 7). 
 
8. Relevance of the antibacterial impregnation (1-no relevant, 5- very relevant). 
 
Figure 3.8. Relevance of the dental prostheses impregnation with an antibacterial (Question 8). 
 
9. Is it important to remove the monomer (MMA) from acrylic prostheses? 
The answers to this question was unanimous, all the orthodontists answered yes-100% Yes 
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Appendix 4: Questionnaire performed to the Portuguese population  
 
A questionnaire about dental prostheses was performed online through the platform “Google Docs”. 
The sample was of 143 Portuguese population and their respective characteristics are presented 
below:  
 
1. Sex:   
 
 
 
Figure 4.1. People who answered to the questionnaire by sex (question 1). 
 
2. Age: 
 
Figure 4.2. Population by age group (question 2). 
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3. Profession 
 
 
Figure 4.3. Population by profession (question 3). 
 
4. What importance does oral hygiene have for you? (1- No importance, 5 –  Very important): 
 
Figure 4.4. Oral hygiene importance (question 4). 
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5. Do you use dental prosthesis? 
 
Figure 4.5. Proportion of dental prosthesis users in the Portuguese population questioned (question 
5). 
 
The number of people who responded “yes” to question 5 is 30, so the following questions were 
answered by them (sample of  30 people), since only dental prosthesis users responded to the 
following questions.    
 
 
Figure 4.6. Dental prosthesis users by age group (question 2) 
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6. Type of dental prosthesis: 
 
Figure 4.7. Proportion of the type of dental prosthesis used by the Portuguese population (question 6). 
 
7. If you use fixed prostheses the process was: 
 
Figure 4-8. Process of putting and adaptation of fixed dental prostheses (question 7). 
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8. Do you have problems with your dental prosthesis (removable or fixed)? 
 
Figure 4.9. Problems with dental prostheses (question 8). 
 
9. If you answer yes, which problem have do you have with your dental prosthesis? 
 
Figure 4.10. Type of problems with dental prostheses (question 9). 
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10. What would you like your dental prosthesis to offer: 
 
Figure 4.11. What dental prosthesis users would like their prosthesis could offer (question 10). 
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Appendix 5: Proof GEI dental concept 
In order to verify the effectiveness of the use of the using supercritical technology for the extraction of 
the MMA from the PMMA used in dental prostheses and in the impregnation of active principals in 
PMMA, experimental test were performed, which are described next. The experimental tests were 
divided in two parts. In a first stage, the possibility to extract the residual monomer from the acrylic 
used in dental prostheses was tested. In a second stage, the possibility of impregnating an anti-
inflammatory drug was evaluated. 
5.1. Reagents and standards 
Table 5.1. Characteristics and manufacturers of the reagents. 
Reagent Formula 
Molar mass 
(g/mol) 
Purity 
(%) 
Manufacturer 
Acetone (CH3)2CO 58.08 >99.5 CarloERBA Reagents 
Acetonitrile CH3CN 41.05 ≥99.8 
LiChrosolv – Merck 
(Darmstadt, Alemanha) 
Carbon 
Dioxide 
CO2 48 99.99 Alphagaz 
Phosphoric 
acid 
H3PO 98 85.0 
Panreac Química S.A.U. 
(Barcelona, Espanha) 
Ibuprofen 
C13H18O2 
 
206.28 _ _ 
Methanol CH3OH 32.04 99.8 
LiChrosolv – Merck 
(Darmstadt, Alemanha) 
Methyl 
methacrylate 
CH2=C(CH3)COOCH3 100.12 95 Self Curing Vertex 
Poly(methyl 
methacrylate) 
(CH2=C(CH3)COOCH3)n _ _ 
Probase Hot Cold (Pink) 
 
 The water used during detection by HPLC was obtained through a system Milli-Q (Milli-Q Mil-
lipore Integral 15, Millipore Corp., France) 
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The acrylic samples used to manufacture dental prostheses and standard of MMA, which were used in 
the experimental tests were given by Professora Catarina Cortes Martins professor of Faculdade de 
Medicina Dentária de Lisboa. The samples are examples of the same material used in dental 
prostheses, in other words, the samples, which were performed in the tests, were acrylic samples of 
the finished material, already to be used by patients. The technology will act after the dental 
prostheses were manufactured. The acrylic samples characteristics and polymerization conditions are 
presented next. 
Table 5.2. Samples characteristics and Conditions of polymerization. 
PMMA samples characteristics 
Probase Hot Cold (Pink) 
 
Type 2 Classe 1 ISO 1567 AOA12 
 
Batch 023891 
Polymerization reaction 
Time (min) Temperature (ºC) Pressure (bar) 
15 55 2,5 
 
Table 5.3. Characteristics of standard of MMA. 
 
 
 
Standard of MMA characteristics 
Self curing Vertex 
 
Type 2 Class 1 ISO 20795-1 
 
Batch XX131L03 
 
Validity: 2016/09 
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5.2. Experimental setup 
The experimental setup used during the test (both extraction and impregnation) is depicted in Figure 
5.1.  
  
 
Figure 5.1. Image of installation where the tests were performed (1- High-pressure cell; 2- CO2 pump 
high pressure liquid; 3-Thermostatized water bath, 4- Pressure manometer). 
 
^_ ^_
 
Figure 5.2. Schematic diagram of the installation where the tests were performed (1- CO2 cylinder; 2-
Cooling coil; 3- High pressure liquid CO2 pump; 4- Valve; 5- Pressure manometer; 6-Micrometer valve; 
7-High-pressure cell; 8- Stir plate; 9-Thermostatized water bath; 10- Flow meter).  
 
        
 
Figure 5.3. High-pressure cell and components used during impregnation tests (1- High-pressure cell; 
1a-basket; 1b-metalic net; 1c- wire support). 
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This apparatus consists in a high-pressure cell (made of stainless steel) with an internal volume of 25 
cm
3
, a high pressure liquid CO2 pump (Haskel Model 29723-71), a water bath and a pressure 
manometer (Digibar II). During the experiments the cell was placed in a thermostatized water bath and 
CO2 was pressurized with a liquid pump. A system of valves allows the CO2 to enter the cell. The 
pressure generator and the cell are provided with an electronic manometer to allow control of the 
pressure and the inlet and outlet of gas. 
5.3.  Detection method  
The High Performance Liquid Chromatography (HPLC) was used to quantify both the residual MMA 
content in the sample after the extraction procedures as well as the ibuprofen impregnated. 
Chromatography is a physic and chemical method of components separation of a given mixture, 
performed throughout the distribution of these components by two phases, which are in contact. 
During the passage of the mobile phase to the stationary phase, the components of the mixture are 
distributed by the two phases, each one being selectively retained by the stationary phase, which 
results in different migrations of these components [75-76]. The stationary phase can be solid or liquid, 
put on a solid support with big superficial area. The mobile phase can be a gas, a liquid or even a 
supercritical fluid, which passes through a stationary phase and carries the different mixture 
components. HPLC is the analytical tool most used in the pharmaceutical industry, the name of liquid 
chromatography is related due to its mobile phase being in a liquid [77]. The HPLC system is 
constituted by a pump, an injector, a column and a detector.   
5.4. Extration Tests 
 
5.4.1. Method  
 
5.4.1.1. Extract tests 
The tests were performed in the equipment showed above in Figure 5.1. The operations’ conditions of 
the test presented in Table 5.4 are in accordance with Kemmere and Hwang [69, 78]. All tests were 
made in duplicate. 
The test consists in immersing the cell with the sample in the thermostated bath of water after the 
desired temperature is reached and subsequently pressurizing it with CO2 until the desired pressure 
(Table 5.4) and stay in contact with CO2 for 20 minutes (static period). After the static period, the 
valves are opened to CO2 pass by the sample continuously for the period presented in Table 5.4, 
namely Continuous Period. Finally, after Continuous Period, the depressurization, the release of SCF, 
was performed at the same flow rate of the Continuous Period. 
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Table.5.4. Operation conditions of extraction tests. 
 
Tests 
    
Sample’s 
Weight 
(mg) 
 
T (ºC) 
 
P bar) 
     
Static 
Period 
(min) 
     
Continuous 
Period    
(min) 
Continuous 
Period        
Flow Rate 
(L/min) 
                
𝝆CO2    
(Kg/m
3
) 
1 265 25 70 20 15 3 743 
2 313 25 70 20 30 3 743 
3 315 40 130 20 30 3 743 
4 298 60 80 20 30       3 191 
 
5.4.1.2. Quantification of MMA extracted 
The quantification of MMA was made by the calibration curve method. A range of standard MMA 
solutions was prepared in methanol in a range of concentrations 10
-4
-10
-6 
mL/mL.  
The protocol to sample destruction to extract the MMA present in each sample is according to 
Ohyama and it is presented below [79]: 
1. The samples after the tests were dissolved in 2 mL of acetone during about 24h.  
2. After 200 µL of previous solution and 800 µL of methanol were put in an 1 mL eppendorf to 
precipitate the polymer (white precipitated is observed). 
3. Centrifugation at 13000 rpm during 3 min and the supernatant was put in a vial in order to be 
detected in the HPLC. 
  
Table 5.5. HPLC conditions used in the analysis of residual monomer. 
 
Analytical column Phenomenex 
Gemini-NX 5µ C18 110A 
(150 X 4,60 mm) 
435814-4 
Oven program Temperature 
40ºC 
Rate 
1.0 mL/min 
 
After the performance of the protocol that led to sample destruction, HPLC analysis was performed 
using the conditions summarized in Table 5.5 which was performed according to Ohyama [79].The 
separation was made in an isocratic way with a mobile phase composed by 50:50 (%v/v) acetonitrile: 
water, with a flow of 1,0 mL.min
-1
. The analytic column of reverse phase used was a 
Phenomenex/Gemini-NX-C18 (150 mm × 4,6 mm, particles size: 5 µm, pore size: 110 Å), coupled to a 
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pre-column of reverse phase, thermostated at 40ºC. The detection was made at 205 nm. The injection 
of each sample was replicated two times, and it was previously filtrated through a 0,45 μm filter. 
5.4.2. Results  
The first stage of experimental test had the objective of verifying if the technology allows the extraction 
of MMA from acrylic resins used in dental prostheses. In order to evaluate this possibility, several tests 
were made at different operational conditions of temperature, pressure and extraction time. 
 
As observed in Table 5.6, different operational conditions led to different extraction efficiencies, in 
addition, it was observed that in some conditions (test 3 and 4) the samples after the tests presented a 
noticeable white color, probably due to the CO2 interaction with the dye. The circular shape, the 
volume and the weight of the samples are maintained after the tests. Assay 2, corresponding to T= 
25ºC and P= 70 bar, presents the best efficiency, about 68.7% of MMA removal, which is a significant 
reduction of MMA with mild operational conditions in a relatively short time and allowed the sample to 
maintain its volume, shape and color after the test. However, a slight whitening of the sample on the 
surface is verified, but it is almost imperceptible. This can be explained by a possible interaction of the 
CO2 with the dye.  
Table 5.6. Extraction process efficiency. 
                 
Tests 
 
Sample’s 
Weight  
(mg) 
 
Concentration 
initial*  
(mL/mL) 
 
Concentration** 
(mL/mL) 
                                                                                                
Efficiency*** 
(%) 
Duration of 
the process 
(min)  
Control 316 0,0045 - - - 
1 265 - 0,004 7.6 35 
2 313 - 0,001 68.7 50 
3 315 - 0,003 39.2 50 
4 298 - 0,003 33.5 50 
* Concentration of MMA present in the sample before the tests. 
** Concentration of MMA remained in the samples after the tests. 
***Efficiency = Amount of MMA extracted by scCO2 / Amount of MMA initially in PMMA 
 
The result obtained in test 2 validates the use of this technology to remove the MMA from dental 
prostheses, and in addition, they are a good starting point for future tests. Therefore, the hypothesis 
that GEI could decrease the amount of MMA in acrylic used in dental prostheses was tested and 
validated. 
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Vanessa Urban has reported a method to extract the residual monomer after polymerization of acrylic 
resins used in prosthodontics [80]. The referred study reports the water-bath (stored in water at 37ºC 
for 48 h) and microwave irradiation (placing them in an adjustable microwave oven (Sensor Crisp 38, 
Brastemp, Manaus, AM, Brazil) and irradiating with: 550 W/3 min) post-polymerization procedure to 
reduce the residual monomer content in acrylic resins. The reduction of MMA from PMMA by these 
methods does not present successful results: “the residual monomer level of the denture base resin 
specimens polymerized (…) was not affected by any of the post-polymerization treatments” [80]. The 
referred methods are not usually dental laboratories procedures. Although this extraction is important 
as previously described in Market Pain chapter, nowadays the extraction of MMA post-polymerization 
is not performed during the dental prosthesis manufacturing in dental laboratories. The test performed 
allows the verification that the GEI dental permits the extraction of MMA from PMMA used in dental 
prostheses. Comparing with the method described by Vanessa Urban it is possible to observe several 
advantages:  
a) The efficiency is superior: GEI dental allows a significant decrease on the MMA level. 
b) Process duration is shorter than the water bath method reported by Vanessa Urban. 
c) GEI dental is a clean and safe technology  
 
5.5. Impregnation Tests  
 
5.5.1. Method 
 
            5.5.1.1. Supercritical Impregnation 
 
The method comprises three steeps: 
1. Solubilization of active principle (solute) in the supercritical fluid (solvent). During the 
impregnation tests, the active principal used was Ibuprofen and the supercritical fluid 
was CO2. 
2. Contact of the matrix impregnated with the supercritical phase, which includes  
the active principal and the supercritical fluid. 
3. Depressurization of the system, which consists in the release of the supercritical fluid 
[81].  
 
The efficiency of the process results of a complex mechanism which involves interactions among the 
solute, solvent and the matrix [82]. The operational parameters that influence the supercritical 
impregnation rate are the CO2 pressure, temperature, impregnation time and the depressurization 
period [81,83].  
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5.1.2.  Active Principle  
The active principle chosen was ibuprofen because it is an anti-inflammatory drug, which is soluble in 
CO2. Ibuprofen is a no steroids anti-inflammatory, it belongs to the sub-group of the derived of 
propionic acid [84-86]. Like the other no steroids anti-inflammatories, it acts inhibiting the production of 
prostaglandins, chemicals produced by the organism which cause inflammation and contribute to the 
pain perception by the brain [83]. This medicine is a white crystalline powder or colorless crystals, 
practically insoluble in water, easily soluble in acetone, methylene chloride, ether and methanol. 
Ibuprofen dissolves in dilute solutions of hydroxides and carbonates of alkali metals (USP 26, 2003). 
Table 5.7.Ibuprofen characteristics.  
 Ibuprofen 
Molecular formule C13H18O2 
Molecular weight 206,28 g/mol 
IUPAC Name (RS)-2-[4-(2-methilpropyl)phenyl]propanoic acid 
Melting point 75-78ºC 
 
 
Figure 5.4. Ibuprofen structure.  
 
1.5.1.3. Conditions of impregnation tests   
The conditions of impregnation were based in the solubility of ibuprofen in scCO2 to ensure the 
solubilization of ibuprofen in scCO2 [87]. The impregnation tests were performed in the equipment 
presented in Figure 5.1 and the conditions used for the impregnation are presented in Table 5.8. The 
tests consist in immersing the cell with acrylic samples and the ibuprofen in the thermostatically bath 
of water until the desired temperature is reached and subsequently pressurizing with CO2 until the 
desired pressure (Table 5.8). During all tests the samples in the cell were stirred. Inside the cell, the 
acrylic samples were put on a wire support and the ibuprofen inside a metallic network, above it. The 
tests were performed in batch during the tCO2 presented in the Table 5.8. After the tCO2, the system 
was depressurized slowly or fastly, according to the test (Table 5.8). 
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Table 5.8. Conditions of impregnation tests. 
Tests 
Sample’s 
weight 
(mg) 
Initial 
Ibuprofen    
(mg) 
T 
(ºC) 
P 
(bar) 
tCO2* 
(min) 
Depressurization 
Period (min) 
𝝆CO2  
(Kg/m
3
) 
5 302 123 50 138 60 30 665 
6 288 119 50 138 60 Fast 665 
7 267 90 35 130 60 30 786 
8 284 90 35 130 30 30 786 
9 122 130 40 130 30 30 743 
10 123 130 40 130 60 30 743 
11 97 100 40 110 30 30 684 
12 113 100 40 110 60 30 684 
13 108 120 40 120 60 30 718 
*Contact period - Period in which sample, active principle and CO2 were in contact. 
5.5.2. Quantification of impregnated ibuprofen 
The protocol to sample destruction to extract the ibuprofen present in each sample is according to 
Ohyama and it is presented below [79]: 
1. The samples after the essays were cleaned with ethanol to remove the ibuprofen which could 
be in the superficies of the samples. 
2. Then the samples were dissolved in 2 or 4 mL (according to the weight samples’) of acetone 
during about 24h.  
3. After 200 µL of previous solution and 800 µL of methanol were put in a 1 mL eppendorf to pre-
cipitate the polymer (white precipitated is observed). 
4. Centrifugation at 13000 rpm during 3 min and the supernatant was put in a vial in order to be 
detected in the HPLC.  
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Table 5.9. Conditions used in analysis of sample content with ibuprofen. 
 
Analytical column Phenomenex 
Gemini-NX 5µ C18 110A 
(150 X 4,60 mm) 
435814-4 
Oven program Temperature 
40ºC 
Rate 
2.0 mL/min 
 
The separation was made in an isocratic way with a mobile phase composed by 60:40 (%v/v) 
acetonitrile: acidificated water with phosphoric acid (pH 2,5), with a flow of 2,0 mL.min-1.  The analytic 
column of reverse phase used was a Phenomenex/Gemini-NX-C18 (150 mm × 4,6 mm, particles size: 
5 µm, pore size: 110 Å), coupled to a pre-column of reverse phase, thermostated to 40ºC. The 
detection was made to 221 nm. The injection of each sample was replicated two times, that was 
previously filtrated through 0,45 μm filter. The quantification of Ibuprofen was made by curve 
calibration method. 
5.5.3. Results 
 
In this second stage of tests, the impregnation of ibuprofen in the acrylic resin used in dental 
prostheses was tested. The objective was to verify whether the active principle is impregnated in 
PMMA by the GEI dental. With the purpose of observing if it is possible to fulfill the objectives, the 
effect of pressure, temperature, CO2 contact and depressurization period were tested.  
Table 5.10 presents the results of impregnation tests which were performed in different operational 
conditions. To validate the use of this technology to impregnate dental prostheses is necessary to 
observe the existence of ibuprofen in the sample. The test 6 was not considered because after the test, 
ibuprofen was only in the surfaces of the sample, so this result allows the verification that slow 
depressurization is a better option than the fast one. In all tests, it is possible to observe that the 
samples are impregnated with ibuprofen, so the technology allows the impregnation of ibuprofen in 
PMMA used in dental prostheses. Different loads were obtained with different temperature and 
pressure conditions, and for some operational conditions, the samples, after the tests, presented a 
different appearance, more translucent with a white color and swelled. This was verified in the tests 
with high pressures and temperatures (tests 5, 6, 9,10 and 13). On the other hand, tests 11 and 12 
present the best loads without changing the samples. After the mentioned tests, the samples 
maintained their circular shape, color and volume. As mentioned above, in extraction experiments, 
only a slight whitening of the sample on the surface is verified, but it is almost imperceptible.  
The operation condition 110 bar and 40ºC seems to be the best conditions to impregnate the PMMA 
with ibuprofen comparing to all the operational conditions tested. The only difference between test 11 
and 12 was the tCO2, it seems to have influence on the loads. For 30 minutes of contact the 
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%impregnation is about 7% and to 60 minutes is about 8%.  The time of the process is an important 
point to take into account. In order to obtain the best process for impregnation to present to the dental 
industry, it is important to evaluate time and efficiency, to have the best combination. 
Table 5.10. Results of impregnation tests. 
Tests 
Depressurization  
period           
(min) 
 
Load* 
 
% 
Impregnation   
** 
                          
% 
Efficiency  
*** 
 
Duration of 
the process 
(min)  
5 30 0.03 3 8.3 90 
6 Fast _ _ _ _ 
7 30 0.01 1 2.5 90 
8 30 0.01 1 3.8 60 
9 30 0,02 2 1.7 60 
10 30 0.02 2 2.0 90 
11 30 0.07 7 6.8 60 
12 30 0.08 8 8.9 90 
13 30 0.09 9 8.0 90 
*Load = impregnated ibuprofen/PMMA 
**%Impregnation = impregnated ibuprofen/PMMA x100 
***Efficiency = impregnated ibuprofen/initial ibuprofen 
  
The results allow considering that the GEI dental enables to impregnate the acrylic resins used in 
dental prostheses. However, only ibuprofen was tested, in other future studies, it is necessary to test 
other active principles, the required by orthodontists, as well as the respective operational conditions 
and the drugs release profile inside the oral cavity, in order to obtain the maximum efficiency of the 
process. The systems of impregnation with different active principle should be studied with more 
detail. The solubility of the drug into CO2, the ability of CO2 to penetrate the polymer and the partition 
coefficient of the drug between the dense gas and the polymer phase are important points to take into 
account during the development of GEI dental.   
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5.6. Conclusion 
The results of the experimental tests allow considering that GEI dental achieves the proposed 
objectives, both for the extraction of MMA and the impregnation with an active principle in dental 
prostheses. The GEI dental enables extracting until 68,7% of MMA present in dental prosthesis in a 
process with that lasts about 50 minutes. In addition GEI dental allows the impregnation of ibuprofen 
with a %impregnation of 7% in a process with the duration of 60 minutes. To increase the 
%impregnation to 8% the duration of the process must also increase to 90 minutes. 
The concept of the product was validated, however it is not yet presented with the best characteristics 
to introduce into the dental market.  Several studies should be done in order to develop the all 
potentialities of this product. The critical points of the GEI dental based on the experimental tests 
made are: 
d) The possible interaction of CO2 with the dye. Nevertheless, there is transparent acrylic without 
dye used in dental industry and, in addition, the composition of the dye is not the best to hu-
man use, probably the dye should be changed in the future, or even this technology could al-
low the impregnation of a safer dye. 
e) The time of the process is an important point to be improved. The demand of dental care sec-
tor is the high efficiency in a shorter period of time possible.  
f) The efficiency of both processes could be improved, it is important to perform future tests in 
order to improve the processes. 
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Appendix 6: Targeting criteria applied to the dental laboratories worldwide 
 
With the purpose of evaluating the companies which have the required characteristic mentioned in 
Chapter 5, section 5.1.2.2, Table 6.2 is presented next, with a list of several dental companies which 
shows an evaluation in the targeting criteria.  Each one will be classified according to what is 
presented in Table 6.1. 
 
Table 6.1. Targeting criteria classification.  
Evaluation Innovation Laboratories in 
Portugal 
Number of laboratories in 
Europe 
Financial 
soundness 
0 Nothing Do not have Do not have 0-5 years  
1 Little 1 laboratory 1-4 laboratories 5-10 years 
2 Medium 2 laboratories 5-10  laboratories 10-30 years 
3 Very More than 3 
laboratories 
More than 10 laboratories More than 30 
years 
 
Table 6.2.  Targeting variables evaluation.  
 
Companies 
 
Innovation 
 
Laboratories 
in Portugal 
 
Country 
 
Number of 
laboratories 
in Europe 
 
Financial 
soundness 
 
Total 
Albilab 0 1 Portugal 1 
0 
2 
Attenborou
gh Dental 
2 0 
UK 1 
3 
6 
Babichenko 
Dental 
Laboratory 
2 0 
USA 0 
2 
 
4 
Bien-Air 3 0 Switzerla
nd 
1 
3 
7 
Bright 
Dental Lab 
1 0 China 0 
1 
2 
Coroadent 0 1 Portugal 1       2 
4 
1
st
 Dental  1 0 UK 3 
      2 
6 
Diagnodent 0 1 Portugal 1 
0 
2 
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Companies 
 
Innovation 
 
Laboratories 
in Portugal 
 
Country 
 
Number of 
laboratories 
in Europe 
 
Financial 
soundness 
 
Total 
Dental 
Services 
Group 
2 0 USA 0 
     3 
5 
Dental 
Union 
Laboratory 
3 0 Poland 1 
    2 
6 
Excel 
Dental Lab 
1 0 Thailand 0 
    3 
4 
Glidewell 
Laboratorie
s 
2 0 USA 0 
    3 
5 
Hi-TECH 0 1 Portugal 1           0 2 
Incisal 0 1 Portugal 1           0 2 
Malo Clinic 
2 1 Portugal 1 
    2 6 
MDH 
2 1 Germany 1 
          1 5 
Mimetik 
0 1 Portugal 1 
    1 
3 
National 
Dentex 
Corporation 
2 0 USA 0 
    2 
4 
Nobel 
Biocare 
 
3 
1 Swiss 3 
    3 
10 
Orallab 2 1 Portugal 1 
    2 
5 
PraticDent 0 1 Portugal 1           2 4 
Proincisal 0 1 Portugal 1           1 3 
Precision 
Dental 
Studio 
3 0 United 
Kingdom 
1 
          3 
 
Sun Dental 
Laboratories 
2 0 USA 2 
    2 
6 
Southern 
Cross 
Dental 
Laboratories 
1 0 Australia 1 
          2 
4 
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Companies 
 
Innovation 
 
Laboratories 
in Portugal 
 
Country 
 
Number of 
laboratories 
in Europe 
 
Financial 
soundness 
 
Total 
Swift Dental 
Group 
2 0 UK 1 
2 
5 
Trident 2 0 USA 0 2 4 
TOKUSHINK
AI 
1 0 Japan 1 
2 4 
Vita 
Zahnfabrik 
(Vita 
Masterlabs) 
 
2 
 
0 
 
Swiss 
 
3 
3 
 
8 
Williams 
dental lab 
2 0 USA 0       3 5 
32Dent 0 1 Portugal 1 1 3 
 
The choice of the dental companies presented in Table 6.2 consisted in a random search of the 
existing companies worldwide and mainly in Portugal. The only criterion of choosing the dental 
companies was the companies’ dental prostheses manufacture and not only dental implants which are 
only made of metal. There are companies which manufacture exclusively metal to dental implants. 
Due to the GEI dental being applied to acrylic, the companies which only sell dental implants are not 
potential customers. 
Table 6.2 presents the dental companies evaluated according to the criterion of Table 6.1. Despite the 
majority of dental laboratories in Portugal being local, with a small dimension and usually only a single 
laboratory and not a network of laboratories, it is possible to verify the existence of influential 
companies in the dental industry in Portugal. Some examples of companies with a strong presence in 
the Portuguese and European market are MDH and Malo Clinic. The above companies have interest 
in advanced and innovative technologies. In addition there are Portuguese dental laboratories, such 
as Orallab, that have interest in innovation and to give a high quality service to their customers. 
Therefore, the mentioned companies are examples of the target customer for GEI dental. The Table 
6.2 gives a global view about some dental companies of the entire world and how they suit in the 
targeting criterion.  
 
 
 
114 
 
 
 
 
 
 
 
 
 
 
 
 
 
115 
 
Appendix 7: SS Financial Plan 
 
